A0NGI1	CGI_10010648	1e-31	TM234_ANOGA	reviewed	Transmembrane protein 234 homolog	AGAP012180	Anopheles gambiae (African malaria mosquito)	140		integral component of membrane [GO:0016021]		integral component of membrane [GO:0016021]	GO:0016021	CGI_10010648	scaffold1127	45024	45026	100	mRNA	43951	45586
A1L2Y1	CGI_10019566	7e-07	FSIP1_XENLA	reviewed	Fibrous sheath-interacting protein 1	fsip1	Xenopus laevis (African clawed frog)	459						CGI_10019566	scaffold1794	46921	46923	-100	mRNA	42711	62714
A2AHJ4	CGI_10020687	0.0	BRWD3_MOUSE	reviewed	Bromodomain and WD repeat-containing protein 3	Brwd3 Gm596	Mus musculus (Mouse)	1799	cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription from RNA polymerase II promoter [GO:0006357]	nucleus [GO:0005634]		nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription from RNA polymerase II promoter [GO:0006357]	GO:0005634; GO:0006357; GO:0007010; GO:0008360	CGI_10020687	scaffold288	633290	633292	100	mRNA	617164	636803
A2AWP0	CGI_10026569	7e-19	BIRC7_MOUSE	reviewed	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (Livin) (RING-type E3 ubiquitin transferase BIRC7) [Cleaved into: Baculoviral IAP repeat-containing protein 7 30 kDa subunit (Truncated livin) (p30-Livin) (tLivin)]	Birc7 Livin	Mus musculus (Mouse)	285	inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247]; regulation of signal transduction [GO:0009966]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247]; regulation of signal transduction [GO:0009966]	GO:0004842; GO:0005634; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0009966; GO:0016567; GO:0042127; GO:0043027; GO:0043066; GO:0046872; GO:0070247; GO:1990001	CGI_10026569	scaffold145	960693	960695	100	mRNA	959637	969232
A2BGR3	CGI_10025557	0.0	ERC6L_DANRE	reviewed	DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like)	ercc6l si:ch211-278b8.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1451	cell cycle [GO:0007049]; cell division [GO:0051301]; intein-mediated protein splicing [GO:0016539]	condensed chromosome kinetochore [GO:0000777]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	condensed chromosome kinetochore [GO:0000777]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; intein-mediated protein splicing [GO:0016539]	GO:0000777; GO:0003677; GO:0004386; GO:0005524; GO:0007049; GO:0016539; GO:0051301	CGI_10025557	scaffold370	652930	652932	100	mRNA	630608	656609
A4D0V7	CGI_10020074	2e-71	CPED1_HUMAN	reviewed	Cadherin-like and PC-esterase domain-containing protein 1	CPED1 C7orf58 UNQ9432/PRO34713	Homo sapiens (Human)	1026		endoplasmic reticulum [GO:0005783]		endoplasmic reticulum [GO:0005783]	GO:0005783	CGI_10020074	scaffold258	549090	549092	100	mRNA	540142	564206
A4IF87	CGI_10011812	2e-148	GNPAT_BOVIN	reviewed	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	GNPAT	Bos taurus (Bovine)	680	ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]	peroxisomal membrane [GO:0005778]	glycerone-phosphate O-acyltransferase activity [GO:0016287]	peroxisomal membrane [GO:0005778]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]	GO:0005778; GO:0006650; GO:0008611; GO:0016287	CGI_10011812	scaffold43692	75103	75105	100	mRNA	63821	78304
A6NHR9	CGI_10013732	0.0	SMHD1_HUMAN	reviewed	Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1)	SMCHD1 KIAA0650	Homo sapiens (Human)	2005	chromosome organization [GO:0051276]; inactivation of X chromosome by DNA methylation [GO:0060821]; nose development [GO:0043584]	Barr body [GO:0001740]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	Barr body [GO:0001740]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromosome organization [GO:0051276]; inactivation of X chromosome by DNA methylation [GO:0060821]; nose development [GO:0043584]	GO:0001740; GO:0005524; GO:0016887; GO:0043584; GO:0051276; GO:0060821	CGI_10013732	scaffold43878	343347	343349	100	mRNA	331528	360286
A6QQ68	CGI_10009117	2e-24	F228B_BOVIN	reviewed	Protein FAM228B	FAM228B	Bos taurus (Bovine)	264						CGI_10009117	scaffold43184	175852	175854	-100	mRNA	172157	193737
A6QQP7	CGI_10024760	0.0	DYSF_BOVIN	reviewed	Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)	DYSF FER1L1	Bos taurus (Bovine)	2107	vesicle fusion [GO:0006906]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; vesicle fusion [GO:0006906]	GO:0005509; GO:0005543; GO:0005886; GO:0006906; GO:0016021; GO:0030659; GO:0042383	CGI_10024760	scaffold70	199391	199393	100	mRNA	171032	212395
A6QR44	CGI_10006425	1e-85	DGCR8_BOVIN	reviewed	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog)	DGCR8	Bos taurus (Bovine)	760	primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091]	cytoplasm [GO:0005737]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]	double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]	cytoplasm [GO:0005737]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091]	GO:0003725; GO:0004525; GO:0005730; GO:0005737; GO:0020037; GO:0031053; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091	CGI_10006425	scaffold1848	64060	64062	100	mRNA	54858	64498
A7YWD2	CGI_10003141	5e-171	IPO13_BOVIN	reviewed	Importin-13 (Imp13)	IPO13	Bos taurus (Bovine)	963	protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]	nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0008565; GO:0031965	CGI_10003141	scaffold985	46856	46858	-100	mRNA	41796	55083
A8MTY0	CGI_10024210	4e-46	ZN724_HUMAN	reviewed	Zinc finger protein 724	ZNF724 ZNF724P	Homo sapiens (Human)	619	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872	CGI_10024210	scaffold392	258123	258125	100	mRNA	255380	263524
B0S5N4	CGI_10010795	2e-08	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; branchiomotor neuron axon guidance [GO:0021785]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of collateral sprouting in absence of injury [GO:0048696]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	protein homodimerization activity [GO:0042803]; semaphorin receptor activity [GO:0017154]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; branchiomotor neuron axon guidance [GO:0021785]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of collateral sprouting in absence of injury [GO:0048696]	GO:0005886; GO:0008045; GO:0016020; GO:0016021; GO:0017154; GO:0021785; GO:0042803; GO:0048675; GO:0048696; GO:0048755; GO:0048841; GO:0060272	CGI_10010795	scaffold1098	65324	65326	-100	mRNA	56507	72093
B0S733	CGI_10001930	2e-33	REN3A_DANRE	reviewed	Regulator of nonsense transcripts 3A (Up-frameshift suppressor 3 homolog A)	upf3a si:dkey-21o13.6	Danio rerio (Zebrafish) (Brachydanio rerio)	452	mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nucleocytoplasmic transport [GO:0006913]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nucleocytoplasmic transport [GO:0006913]	GO:0000184; GO:0003723; GO:0005634; GO:0005737; GO:0006913; GO:0051028	CGI_10001930	scaffold36462	28206	28208	-100	mRNA	28109	34499
B0W2S0	CGI_10014051	0.0	CLU_CULQU	reviewed	Clustered mitochondria protein homolog	CPIJ001445	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	1377	intracellular distribution of mitochondria [GO:0048312]	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312]	GO:0005737; GO:0048312	CGI_10014051	scaffold1803	248665	248667	100	mRNA	233210	248683
B1H1P9	CGI_10006634	2e-71	PPAL_XENLA	reviewed	Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)	acp2	Xenopus laevis (African clawed frog)	432		integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]	acid phosphatase activity [GO:0003993]	integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]	GO:0003993; GO:0005765; GO:0016021; GO:0043202	CGI_10006634	scaffold281	119858	119860	100	mRNA	116134	127065
B4U7S7	CGI_10005632	7e-28	Y501_HYDS0	reviewed	Probable transcriptional regulatory protein HY04AAS1_0501	HY04AAS1_0501	Hydrogenobaculum sp. (strain Y04AAS1)	249	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]	DNA binding [GO:0003677]	cytoplasm [GO:0005737]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005737; GO:0006351; GO:0006355	CGI_10005632	scaffold41792	6083	6085	100	mRNA	1797	7186
B5FZ19	CGI_10025943	2e-173	EIF3I_TAEGU	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (eIF-3-beta) (eIF3 p36)	EIF3I EIF3S2	Taeniopygia guttata (Zebra finch) (Poephila guttata)	325	translational initiation [GO:0006413]	eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]	GO:0003743; GO:0005852; GO:0006413	CGI_10025943	scaffold334	506323	506325	100	mRNA	502315	506735
B5X2B8	CGI_10005915	4e-53	ERAL1_SALSA	reviewed	GTPase Era, mitochondrial (ERA-like protein 1)	eral1	Salmo salar (Atlantic salmon)	457	ribosomal small subunit assembly [GO:0000028]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]	GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; ribosomal small subunit assembly [GO:0000028]	GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024	CGI_10005915	scaffold41998	112429	112431	100	mRNA	107642	122323
E1B7X9	CGI_10025169	0.0	SMRCD_BOVIN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12)	SMARCAD1	Bos taurus (Bovine)	1028	ATP-dependent chromatin remodeling [GO:0043044]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]	heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]	GO:0000018; GO:0000729; GO:0000792; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0035861; GO:0043044; GO:0043596; GO:0051304; GO:0070932; GO:0070933	CGI_10025169	scaffold1267	739106	739108	-100	mRNA	738355	760622
E1C1R4	CGI_10004725	0.0	UBP47_CHICK	reviewed	Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47)	USP47	Gallus gallus (Chicken)	1375	base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0004843; GO:0005737; GO:0006284; GO:0006511; GO:0006974; GO:0035520; GO:0042981; GO:0045892	CGI_10004725	scaffold41136	51038	51040	100	mRNA	5469	74857
E1C2Z0	CGI_10024637	3e-82	MMS22_CHICK	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	MMS22L	Gallus gallus (Chicken)	1243	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	GO:0000724; GO:0031297; GO:0043596	CGI_10024637	scaffold79	579548	579550	-100	mRNA	571723	588134
F8WLE0	CGI_10018571	9e-160	KIF28_RAT	reviewed	Kinesin-like protein KIF28P (Kinesin-like protein 6)	Kif28p Klp6	Rattus norvegicus (Rat)	1034	mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]	intracellular [GO:0005622]; kinesin complex [GO:0005871]; mitochondrial membrane [GO:0031966]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	intracellular [GO:0005622]; kinesin complex [GO:0005871]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]	GO:0003777; GO:0005524; GO:0005622; GO:0005871; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0072384	CGI_10018571	scaffold412	273982	273984	100	mRNA	269312	279045
O00410	CGI_10013799	0.0	IPO5_HUMAN	reviewed	Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5)	IPO5 KPNB3 RANBP5	Homo sapiens (Human)	1097	cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus, translocation [GO:0000060]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]	GTPase inhibitor activity [GO:0005095]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus, translocation [GO:0000060]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032]	GO:0000060; GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005730; GO:0005737; GO:0006607; GO:0006610; GO:0008139; GO:0008536; GO:0008565; GO:0016020; GO:0016032; GO:0031965; GO:0034399; GO:0042307; GO:0071230	CGI_10013799	scaffold1827	117295	117297	-100	mRNA	104854	119662
O08550	CGI_10008103	2e-112	KMT2B_MOUSE	reviewed	Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)	Kmt2b Mll2 Trx2 Wbp7	Mus musculus (Mouse)	2713	gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0001541; GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0030728; GO:0034968; GO:0035097; GO:0042800; GO:0051568; GO:0051569; GO:0080182	CGI_10008103	scaffold42904	105177	105179	100	mRNA	87880	118208
O08839	CGI_10012930	3e-08	BIN1_RAT	reviewed	Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Bridging integrator 1)	Bin1 Amph2 Amphl	Rattus norvegicus (Rat)	588	endocytosis [GO:0006897]; lipid tube assembly [GO:0060988]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle arrest [GO:0071156]; regulation of neuron differentiation [GO:0045664]	axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; I band [GO:0031674]; lipid tube [GO:0060987]; microtubule [GO:0005874]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; Z disc [GO:0030018]	GTPase binding [GO:0051020]; protein complex binding [GO:0032403]; protein heterodimerization activity [GO:0046982]	axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; I band [GO:0031674]; lipid tube [GO:0060987]; microtubule [GO:0005874]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; Z disc [GO:0030018]; GTPase binding [GO:0051020]; protein complex binding [GO:0032403]; protein heterodimerization activity [GO:0046982]; endocytosis [GO:0006897]; lipid tube assembly [GO:0060988]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle arrest [GO:0071156]; regulation of neuron differentiation [GO:0045664]	GO:0005634; GO:0005874; GO:0006897; GO:0008021; GO:0030018; GO:0030315; GO:0030424; GO:0031674; GO:0032403; GO:0033268; GO:0043065; GO:0043194; GO:0043196; GO:0043547; GO:0043679; GO:0044300; GO:0045664; GO:0045807; GO:0046982; GO:0048711; GO:0051020; GO:0060987; GO:0060988; GO:0071156	CGI_10012930	scaffold5	245281	245283	100	mRNA	241543	248968
O14832	CGI_10008109	1e-140	PAHX_HUMAN	reviewed	Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)	PHYH PAHX	Homo sapiens (Human)	338	2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]	GO:0001561; GO:0005739; GO:0005777; GO:0005782; GO:0006103; GO:0006720; GO:0008198; GO:0031406; GO:0031418; GO:0048037; GO:0048244; GO:0097089	CGI_10008109	scaffold694	130521	130523	-100	mRNA	127285	137031
O14981	CGI_10003467	0.0	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; transcription factor activity, sequence-specific DNA binding [GO:0003700]	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]	GO:0003677; GO:0003700; GO:0004386; GO:0005524; GO:0005654; GO:0035562; GO:0043231; GO:0045892	CGI_10003467	scaffold39634	24044	24046	100	mRNA	15924	31196
O15027	CGI_10027751	4e-123	SC16A_HUMAN	reviewed	Protein transport protein Sec16A (SEC16 homolog A)	SEC16A KIAA0310 SEC16 SEC16L	Homo sapiens (Human)	2179	COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]		cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031]; substantia nigra development [GO:0021762]	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0007029; GO:0015031; GO:0021762; GO:0048208	CGI_10027751	scaffold1301	958700	958702	-100	mRNA	940827	961246
O15182	CGI_10026181	2e-93	CETN3_HUMAN	reviewed	Centrin-3	CETN3 CEN3	Homo sapiens (Human)	167	cell division [GO:0051301]; centrosome cycle [GO:0007098]	centriole [GO:0005814]; centrosome [GO:0005813]; nucleolus [GO:0005730]	calcium ion binding [GO:0005509]	centriole [GO:0005814]; centrosome [GO:0005813]; nucleolus [GO:0005730]; calcium ion binding [GO:0005509]; cell division [GO:0051301]; centrosome cycle [GO:0007098]	GO:0005509; GO:0005730; GO:0005813; GO:0005814; GO:0007098; GO:0051301	CGI_10026181	scaffold1154	648536	648538	100	mRNA	641731	648608
O15400	CGI_10025330	1e-55	STX7_HUMAN	reviewed	Syntaxin-7	STX7	Homo sapiens (Human)	261	intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; tertiary granule [GO:0070820]; vesicle [GO:0031982]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076	CGI_10025330	scaffold149	903350	903352	100	mRNA	897350	904187
O29230	CGI_10006664	7e-07	RAD50_ARCFU	reviewed	DNA double-strand break repair Rad50 ATPase	rad50 AF_1032	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	886	DNA repair [GO:0006281]		ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]	GO:0005524; GO:0006281; GO:0016787; GO:0046872	CGI_10006664	scaffold536	10839	10841	100	mRNA	9032	12426
O35134	CGI_10014460	0.0	RPA1_MOUSE	reviewed	DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194)	Polr1a Rpa1 Rpo1-4	Mus musculus (Mouse)	1717	chromatin silencing at rDNA [GO:0000183]; negative regulation of protein localization to nucleolus [GO:1904750]; transcription initiation from RNA polymerase I promoter [GO:0006361]	DNA-directed RNA polymerase I complex [GO:0005736]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]	DNA-directed RNA polymerase I complex [GO:0005736]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; chromatin silencing at rDNA [GO:0000183]; negative regulation of protein localization to nucleolus [GO:1904750]; transcription initiation from RNA polymerase I promoter [GO:0006361]	GO:0000183; GO:0001054; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005736; GO:0006361; GO:0008270; GO:1904750	CGI_10014460	scaffold890	56122	56124	100	mRNA	46122	73210
O43826	CGI_10004606	6e-79	G6PT1_HUMAN	reviewed	Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19)	SLC37A4 G6PT G6PT1 PRO0685 TRG19	Homo sapiens (Human)	429	glucose-6-phosphate transport [GO:0015760]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose transport [GO:0015758]; phosphate ion transmembrane transport [GO:0035435]; transport [GO:0006810]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152]; transporter activity [GO:0005215]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152]; transporter activity [GO:0005215]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose transport [GO:0015758]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]; transport [GO:0006810]	GO:0005215; GO:0005783; GO:0005789; GO:0006006; GO:0006810; GO:0015152; GO:0015758; GO:0015760; GO:0016020; GO:0016021; GO:0030176; GO:0035435; GO:0042593; GO:0061513	CGI_10004606	scaffold40980	79339	79341	-100	mRNA	79073	90416
O43913	CGI_10010442	2e-153	ORC5_HUMAN	reviewed	Origin recognition complex subunit 5	ORC5 ORC5L	Homo sapiens (Human)	435	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]	cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]	cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]	GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270	CGI_10010442	scaffold1858	56406	56408	100	mRNA	49788	62820
O46037	CGI_10014632	0.0	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]	GO:0003779; GO:0005198; GO:0005737; GO:0005925; GO:0006909; GO:0007016; GO:0007155; GO:0015629; GO:0048812; GO:0051015; GO:0098592	CGI_10014632	scaffold43956	323653	323655	100	mRNA	301996	328172
O54701	CGI_10009078	1e-117	NCKX2_RAT	reviewed	Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2)	Slc24a2 Nckx2	Rattus norvegicus (Rat)	670	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]	cadmium ion binding [GO:0046870]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; nickel cation binding [GO:0016151]; potassium ion binding [GO:0030955]; protein dimerization activity [GO:0046983]; sodium ion binding [GO:0031402]; symporter activity [GO:0015293]	integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; cadmium ion binding [GO:0046870]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium, potassium:sodium antiporter activity [GO:0008273]; manganese ion binding [GO:0030145]; nickel cation binding [GO:0016151]; potassium ion binding [GO:0030955]; protein dimerization activity [GO:0046983]; sodium ion binding [GO:0031402]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	GO:0005262; GO:0005509; GO:0005887; GO:0006874; GO:0007601; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016151; GO:0030145; GO:0030955; GO:0031226; GO:0031402; GO:0046870; GO:0046983; GO:0050896; GO:0060291; GO:0060292; GO:0070588	CGI_10009078	scaffold1616	198913	198915	100	mRNA	186394	205716
O60306	CGI_10006403	0.0	AQR_HUMAN	reviewed	Intron-binding protein aquarius (Intron-binding protein of 160 kDa) (IBP160)	AQR KIAA0560	Homo sapiens (Human)	1485	mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]	GO:0000398; GO:0003723; GO:0005654; GO:0006283; GO:0016020; GO:0071013	CGI_10006403	scaffold42236	79598	79600	-100	mRNA	70910	88740
O60504	CGI_10021679	7e-42	VINEX_HUMAN	reviewed	Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3)	SORBS3 SCAM1	Homo sapiens (Human)	671	actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; muscle contraction [GO:0006936]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	structural constituent of cytoskeleton [GO:0005200]; transcription factor binding [GO:0008134]; vinculin binding [GO:0017166]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; transcription factor binding [GO:0008134]; vinculin binding [GO:0017166]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; muscle contraction [GO:0006936]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496]	GO:0000122; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005925; GO:0006936; GO:0007015; GO:0007155; GO:0008134; GO:0017166; GO:0031589; GO:0043410; GO:0051495; GO:0051496	CGI_10021679	scaffold1032	370264	370266	100	mRNA	344097	412046
O61577	CGI_10016028	3e-170	KTNA1_STRPU	reviewed	Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 3.6.4.3) (p60 katanin)	KATNA1	Strongylocentrotus purpuratus (Purple sea urchin)	516	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0030496; GO:0051013; GO:0051301	CGI_10016028	scaffold504	249044	249046	100	mRNA	245472	293737
O75096	CGI_10026155	0.0	LRP4_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	1905	BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway involved in dorsal/ventral axis specification [GO:0044332]	cell surface [GO:0009986]; dendrite [GO:0030425]; flotillin complex [GO:0016600]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	cell surface [GO:0009986]; dendrite [GO:0030425]; flotillin complex [GO:0016600]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway involved in dorsal/ventral axis specification [GO:0044332]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016600; GO:0017147; GO:0030279; GO:0030425; GO:0030509; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0042813; GO:0043025; GO:0043235; GO:0044332; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:1901631; GO:1904395	CGI_10026155	scaffold1154	154046	154048	-100	mRNA	126524	188335
O75165	CGI_10021563	0.0	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	CGI_10021563	scaffold973	641204	641206	100	mRNA	610551	648341
O75417	CGI_10013103	0.0	DPOLQ_HUMAN	reviewed	DNA polymerase theta (EC 2.7.7.7) (DNA polymerase eta)	POLQ POLH	Homo sapiens (Human)	2590	base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; single-stranded DNA-dependent ATPase activity [GO:0043142]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; single-stranded DNA-dependent ATPase activity [GO:0043142]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	GO:0000724; GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0043142; GO:0051260; GO:0051575; GO:0097681; GO:2000042	CGI_10013103	scaffold43842	173289	173291	100	mRNA	160282	183977
O75445	CGI_10014850	0.0	USH2A_HUMAN	reviewed	Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein)	USH2A	Homo sapiens (Human)	5202	establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]	collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	GO:0001917; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016021; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042803; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060113; GO:0060171; GO:1990075; GO:1990696	CGI_10014850	scaffold767	343589	343591	100	mRNA	315899	380131
O75533	CGI_10007640	0.0	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071013	CGI_10007640	scaffold640	94044	94046	-100	mRNA	92126	109820
O75596	CGI_10024415	2e-08	CLC3A_HUMAN	reviewed	C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin)	CLEC3A CLECSF1 UNQ700/PRO1345	Homo sapiens (Human)	197	skeletal system development [GO:0001501]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; skeletal system development [GO:0001501]	GO:0001501; GO:0005576; GO:0030246	CGI_10024415	scaffold784	191331	191333	-100	mRNA	178600	195281
O75643	CGI_10018964	0.0	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]	GO:0000354; GO:0000398; GO:0001649; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0008026; GO:0016020; GO:0042802; GO:0046540; GO:0071013	CGI_10018964	scaffold658	120105	120107	-100	mRNA	98902	126256
O75665	CGI_10010882	7e-89	OFD1_HUMAN	reviewed	Oral-facial-digital syndrome 1 protein (Protein 71-7A)	OFD1 CXorf5	Homo sapiens (Human)	1012	ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]	GO:0000086; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0016020; GO:0034451; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060271; GO:0060287; GO:0097711	CGI_10010882	scaffold43574	233194	233196	100	mRNA	230613	242715
O75891	CGI_10014314	0.0	AL1L1_HUMAN	reviewed	Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)	ALDH1L1 FTHFD	Homo sapiens (Human)	902	10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	aldehyde dehydrogenase (NAD) activity [GO:0004029]; catalytic activity [GO:0003824]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; catalytic activity [GO:0003824]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]	GO:0003824; GO:0004029; GO:0005739; GO:0005829; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016742; GO:0046655; GO:0070062	CGI_10014314	scaffold737	216573	216575	100	mRNA	207639	239787
O88974	CGI_10026622	2e-85	SETB1_MOUSE	reviewed	Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.43) (ERG-associated protein with SET domain) (ESET) (SET domain bifurcated 1)	Setdb1 Eset Kiaa0067	Mus musculus (Mouse)	1307	bone development [GO:0060348]; histone H3-K9 trimethylation [GO:0036124]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]; transcription, DNA-templated [GO:0006351]	chromosome [GO:0005694]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]	chromosome [GO:0005694]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; histone H3-K9 trimethylation [GO:0036124]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]; transcription, DNA-templated [GO:0006351]	GO:0000122; GO:0001833; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005886; GO:0006351; GO:0007265; GO:0008270; GO:0018024; GO:0036124; GO:0043231; GO:0060348; GO:0090309; GO:1990841	CGI_10026622	scaffold313	752980	752982	100	mRNA	734660	773846
O94913	CGI_10027261	2e-48	PCF11_HUMAN	reviewed	Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11)	PCF11 KIAA0824	Homo sapiens (Human)	1555	mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA polymerase II core binding [GO:0000993]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II core binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]	GO:0000398; GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379; GO:0031124	CGI_10027261	scaffold481	1081971	1081973	-100	mRNA	1067271	1084850
P00491	CGI_10017694	5e-97	PNPH_HUMAN	reviewed	Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase)	PNP NP	Homo sapiens (Human)	289	immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine-containing compound salvage [GO:0043101]; purine nucleotide catabolic process [GO:0006195]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418]	GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005622; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006139; GO:0006148; GO:0006195; GO:0006738; GO:0006955; GO:0008144; GO:0034356; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042493; GO:0043101; GO:0043312; GO:0046638; GO:0070062; GO:0070970; GO:1904813	CGI_10017694	scaffold44098	8043	8045	-100	mRNA	4117	10851
P04183	CGI_10024169	2e-82	KITH_HUMAN	reviewed	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	Homo sapiens (Human)	234	DNA biosynthetic process [GO:0071897]; DNA metabolic process [GO:0006259]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]	cytosol [GO:0005829]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleoside kinase activity [GO:0019206]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleoside kinase activity [GO:0019206]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]; DNA biosynthetic process [GO:0071897]; DNA metabolic process [GO:0006259]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]	GO:0004797; GO:0005524; GO:0005829; GO:0006139; GO:0006259; GO:0008270; GO:0019206; GO:0042802; GO:0043097; GO:0046104; GO:0051289; GO:0071897	CGI_10024169	scaffold485	488245	488247	100	mRNA	483058	490355
P05455	CGI_10005904	4e-25	LA_HUMAN	reviewed	Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B)	SSB	Homo sapiens (Human)	408	histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]	cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	GO:0000049; GO:0000784; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0030529; GO:0042780; GO:0071045; GO:0075522; GO:1903608; GO:1990825	CGI_10005904	scaffold41974	81235	81237	-100	mRNA	75674	89547
P07207	CGI_10022703	0.0	NOTCH_DROME	reviewed	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	N CG3936	Drosophila melanogaster (Fruit fly)	2703	actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; epithelium development [GO:0060429]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuroblast fate determination [GO:0007400]; neurological system process [GO:0050877]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glucose metabolic process [GO:0010906]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; subapical complex [GO:0035003]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; epithelium development [GO:0060429]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuroblast fate determination [GO:0007400]; neurological system process [GO:0050877]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glucose metabolic process [GO:0010906]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]	GO:0000122; GO:0001708; GO:0001745; GO:0002213; GO:0003682; GO:0004872; GO:0004888; GO:0005509; GO:0005622; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0006351; GO:0007015; GO:0007155; GO:0007157; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007424; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007460; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010629; GO:0010906; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0035003; GO:0035153; GO:0035155; GO:0035157; GO:0035162; GO:0035165; GO:0035167; GO:0035170; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043234; GO:0045316; GO:0045463; GO:0045465; GO:0045466; GO:0045468; GO:0045595; GO:0045747; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048666; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060429; GO:0061331; GO:0061382; GO:1900087; GO:2000048	CGI_10022703	scaffold364	565787	565789	100	mRNA	539796	598969
P08183	CGI_10015978	0.0	MDR1_HUMAN	reviewed	Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243)	ABCB1 MDR1 PGY1	Homo sapiens (Human)	1280	ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085]; transport [GO:0006810]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic-transporting ATPase activity [GO:0008559]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic-transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085]; transport [GO:0006810]	GO:0000086; GO:0005215; GO:0005524; GO:0005886; GO:0006810; GO:0008559; GO:0009986; GO:0016020; GO:0016021; GO:0016324; GO:0042493; GO:0042626; GO:0045332; GO:0047484; GO:0055085; GO:0070062; GO:0072089; GO:0090554; GO:0090555; GO:0099038; GO:0099040; GO:1901529; GO:2001225	CGI_10015978	scaffold527	146122	146124	100	mRNA	118527	155783
P09487	CGI_10014131	8e-107	PPBT_BOVIN	reviewed	Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)	ALPL	Bos taurus (Bovine)	524	biomineral tissue development [GO:0031214]; cellular response to organic cyclic compound [GO:0071407]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; osteoblast differentiation [GO:0001649]; response to antibiotic [GO:0046677]; response to vitamin D [GO:0033280]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; proteinaceous extracellular matrix [GO:0005578]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; proteinaceous extracellular matrix [GO:0005578]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; biomineral tissue development [GO:0031214]; cellular response to organic cyclic compound [GO:0071407]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; osteoblast differentiation [GO:0001649]; response to antibiotic [GO:0046677]; response to vitamin D [GO:0033280]	GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0005578; GO:0005886; GO:0016462; GO:0031214; GO:0031225; GO:0033280; GO:0046677; GO:0046872; GO:0065010; GO:0070062; GO:0071407	CGI_10014131	scaffold43932	365281	365283	-100	mRNA	361197	374116
P09623	CGI_10028528	0.0	DLDH_PIG	reviewed	Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)	DLD LAD	Sus scrofa (Pig)	509	cell redox homeostasis [GO:0045454]	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; motile cilium [GO:0031514]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; motile cilium [GO:0031514]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]	GO:0001669; GO:0004148; GO:0005759; GO:0031514; GO:0045454; GO:0050660	CGI_10028528	scaffold1024	215501	215503	100	mRNA	191784	246938
P0C8Z3	CGI_10005033	0.0	UBP22_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	USP22	Bos taurus (Bovine)	514	cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]	SAGA complex [GO:0000124]	enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	SAGA complex [GO:0000124]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0000124; GO:0004843; GO:0006351; GO:0006511; GO:0007049; GO:0008270; GO:0010485; GO:0016574; GO:0016578; GO:0019899; GO:0030374; GO:0045893; GO:0045931	CGI_10005033	scaffold41400	64072	64074	100	mRNA	56733	66697
P10076	CGI_10015140	4e-34	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	regulation of transcription, DNA-templated [GO:0006355]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	CGI_10015140	scaffold1671	165297	165299	100	mRNA	163025	167836
P10351	CGI_10012473	9e-145	XDH_DROME	reviewed	Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus)	ry XDH CG7642	Drosophila melanogaster (Fruit fly)	1335	arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ethanol [GO:0045471]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]	cytosol [GO:0005829]; peroxisome [GO:0005777]	2 iron, 2 sulfur cluster binding [GO:0051537]; electron carrier activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO:0016903]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]	cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron carrier activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO:0016903]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ethanol [GO:0045471]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0006144; GO:0006206; GO:0006525; GO:0006568; GO:0006650; GO:0008340; GO:0009055; GO:0009115; GO:0016614; GO:0016903; GO:0043546; GO:0045471; GO:0048072; GO:0050660; GO:0051537	CGI_10012473	scaffold765	223039	223041	100	mRNA	207882	228566
P11087	CGI_10019649	3e-15	CO1A1_MOUSE	reviewed	Collagen alpha-1(I) chain (Alpha-1 type I collagen)	Col1a1 Cola1	Mus musculus (Mouse)	1453	blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to peptide hormone [GO:0043434]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]	collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; proteinaceous extracellular matrix [GO:0005578]; secretory granule [GO:0030141]	extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]	collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; proteinaceous extracellular matrix [GO:0005578]; secretory granule [GO:0030141]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to peptide hormone [GO:0043434]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]	GO:0001501; GO:0001568; GO:0001649; GO:0001957; GO:0001958; GO:0002020; GO:0005201; GO:0005578; GO:0005581; GO:0005584; GO:0005615; GO:0005737; GO:0005783; GO:0005794; GO:0007601; GO:0007605; GO:0010718; GO:0010812; GO:0015031; GO:0030141; GO:0030199; GO:0030335; GO:0031012; GO:0031960; GO:0032355; GO:0032964; GO:0034504; GO:0034505; GO:0038063; GO:0042060; GO:0042493; GO:0042542; GO:0042802; GO:0043434; GO:0043588; GO:0043589; GO:0044344; GO:0044691; GO:0045893; GO:0046872; GO:0048407; GO:0048705; GO:0048706; GO:0051591; GO:0055093; GO:0060325; GO:0060346; GO:0060351; GO:0070208; GO:0071230; GO:0071260; GO:0071300; GO:0071306; GO:0071356; GO:0071364; GO:0071560; GO:0090263; GO:1902618	CGI_10019649	scaffold1896	394522	394524	100	mRNA	382396	395686
P11276	CGI_10001789	2e-13	FINC_MOUSE	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	Fn1	Mus musculus (Mouse)	2477	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; integrin activation [GO:0033622]; interaction with other organism via secreted substance involved in symbiotic interaction [GO:0052047]; interaction with symbiont [GO:0051702]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; peptide cross-linking [GO:0018149]; positive regulation of axon extension [GO:0045773]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; substrate adhesion-dependent cell spreading [GO:0034446]; wound healing [GO:0042060]	apical plasma membrane [GO:0016324]; basal lamina [GO:0005605]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; proteinaceous extracellular matrix [GO:0005578]	chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; receptor binding [GO:0005102]	apical plasma membrane [GO:0016324]; basal lamina [GO:0005605]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; proteinaceous extracellular matrix [GO:0005578]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; integrin activation [GO:0033622]; interaction with other organism via secreted substance involved in symbiotic interaction [GO:0052047]; interaction with symbiont [GO:0051702]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; peptide cross-linking [GO:0018149]; positive regulation of axon extension [GO:0045773]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; substrate adhesion-dependent cell spreading [GO:0034446]; wound healing [GO:0042060]	GO:0001525; GO:0001932; GO:0002020; GO:0005102; GO:0005178; GO:0005577; GO:0005578; GO:0005604; GO:0005605; GO:0005615; GO:0005793; GO:0006953; GO:0007044; GO:0007155; GO:0007160; GO:0007161; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0010628; GO:0016324; GO:0016504; GO:0018149; GO:0019899; GO:0031012; GO:0033622; GO:0034446; GO:0035987; GO:0042060; GO:0042802; GO:0045773; GO:0048146; GO:0051087; GO:0051702; GO:0052047; GO:0070062; GO:0070372; GO:0072562; GO:0097718; GO:1904237; GO:2001202	CGI_10001789	scaffold36094	11678	11680	-100	mRNA	850	27457
P13395	CGI_10025721	0.0	SPTCA_DROME	reviewed	Spectrin alpha chain	alpha-Spec SPEC-A CG1977	Drosophila melanogaster (Fruit fly)	2415	actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]	basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007293; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008091; GO:0008092; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693; GO:0060429	CGI_10025721	scaffold354	512367	512369	100	mRNA	500565	523276
P13666	CGI_10008403	6e-09	SRCA_RABIT	reviewed	Sarcalumenin	SRL	Oryctolagus cuniculus (Rabbit)	908		sarcoplasmic reticulum lumen [GO:0033018]	GTP binding [GO:0005525]	sarcoplasmic reticulum lumen [GO:0033018]; GTP binding [GO:0005525]	GO:0005525; GO:0033018	CGI_10008403	scaffold726	78919	78921	-100	mRNA	76896	97309
P13667	CGI_10019057	0.0	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0045454; GO:0061077	CGI_10019057	scaffold1249	210763	210765	100	mRNA	209452	218345
P17439	CGI_10005801	3e-83	GLCM_MOUSE	reviewed	Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase)	Gba	Mus musculus (Mouse)	515	autophagosome organization [GO:1905037]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glucosylceramide catabolic process [GO:0006680]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of water loss via skin [GO:0033561]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]	glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; receptor binding [GO:0005102]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; receptor binding [GO:0005102]; autophagosome organization [GO:1905037]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glucosylceramide catabolic process [GO:0006680]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of water loss via skin [GO:0033561]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]	GO:0004348; GO:0005102; GO:0005615; GO:0005765; GO:0006680; GO:0009267; GO:0009268; GO:0016787; GO:0023021; GO:0032268; GO:0032269; GO:0032436; GO:0032463; GO:0032715; GO:0033561; GO:0033574; GO:0035307; GO:0043202; GO:0043243; GO:0043407; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0051246; GO:0051247; GO:0051384; GO:0070062; GO:0071356; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037	CGI_10005801	scaffold41896	2964	2966	100	mRNA	253	10977
P22292	CGI_10007140	1e-135	M2OM_BOVIN	reviewed	Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11)	SLC25A11 SLC20A4	Bos taurus (Bovine)	314	mitochondrial transport [GO:0006839]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; mitochondrial transport [GO:0006839]	GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0006839; GO:0015367; GO:0016021	CGI_10007140	scaffold42540	118339	118341	100	mRNA	114562	120170
P22793	CGI_10023442	2e-15	TRHY_SHEEP	reviewed	Trichohyalin	TCHH THH	Ovis aries (Sheep)	1549	keratinization [GO:0031424]		calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; keratinization [GO:0031424]	GO:0005509; GO:0031424; GO:0046914	CGI_10023442	scaffold625	834608	834610	-100	mRNA	813732	836236
P23634	CGI_10023684	0.0	AT2B4_HUMAN	reviewed	Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 3.6.3.8) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)	ATP2B4 ATP2B2 MXRA1	Homo sapiens (Human)	1241	calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adrenergic receptor signaling pathway involved in heart process [GO:1901205]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adrenergic receptor signaling pathway involved in heart process [GO:1901205]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]	GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010751; GO:0016020; GO:0016323; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0033138; GO:0034220; GO:0036126; GO:0036487; GO:0043005; GO:0043231; GO:0043234; GO:0045019; GO:0046872; GO:0050998; GO:0051001; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:1900082; GO:1901205; GO:1901660; GO:1902083; GO:1902305; GO:1902806; GO:1903243; GO:1903249; GO:1903779; GO:2000481	CGI_10023684	scaffold54	465990	465992	100	mRNA	458821	492283
P23913	CGI_10025955	1e-148	LBR_CHICK	reviewed	Lamin-B receptor	LBR	Gallus gallus (Chicken)	637	sterol biosynthetic process [GO:0016126]	integral component of nuclear inner membrane [GO:0005639]	DNA binding [GO:0003677]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]	integral component of nuclear inner membrane [GO:0005639]; DNA binding [GO:0003677]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; sterol biosynthetic process [GO:0016126]	GO:0003677; GO:0005639; GO:0016126; GO:0016627; GO:0016628	CGI_10025955	scaffold334	629204	629206	100	mRNA	627021	650676
P24928	CGI_10021948	0.0	RPB1_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48)	POLR2A POLR2	Homo sapiens (Human)	1970	7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription, termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription, DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription from RNA polymerase II promoter [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	DNA-directed RNA polymerase II, core complex [GO:0005665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]	DNA-directed RNA polymerase II, core complex [GO:0005665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; 7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription, termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription, DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription from RNA polymerase II promoter [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]	GO:0000398; GO:0003677; GO:0003723; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006353; GO:0006355; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0031625; GO:0033120; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	CGI_10021948	scaffold1086	483745	483747	-100	mRNA	467526	495412
P25228	CGI_10021960	5e-133	RAB3_DROME	reviewed	Ras-related protein Rab-3	Rab3 CG7576	Drosophila melanogaster (Fruit fly)	220	cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle-mediated transport [GO:0016192]	cell junction [GO:0030054]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	cell junction [GO:0030054]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle-mediated transport [GO:0016192]	GO:0003924; GO:0005525; GO:0006887; GO:0007269; GO:0008021; GO:0015031; GO:0016192; GO:0030054; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0048172; GO:0048786; GO:0048789; GO:0048790	CGI_10021960	scaffold1108	114173	114175	-100	mRNA	111668	118247
P27600	CGI_10020412	1e-162	GNA12_MOUSE	reviewed	Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12)	Gna12 Gna-12	Mus musculus (Mouse)	379	adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to drug [GO:0042493]; Rho protein signal transduction [GO:0007266]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]	D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; signal transducer activity [GO:0004871]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; signal transducer activity [GO:0004871]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G-protein coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to drug [GO:0042493]; Rho protein signal transduction [GO:0007266]	GO:0001701; GO:0003924; GO:0004871; GO:0005525; GO:0005737; GO:0005834; GO:0005925; GO:0007186; GO:0007188; GO:0007266; GO:0008360; GO:0010762; GO:0016328; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0035556; GO:0042493; GO:0042733; GO:0046872	CGI_10020412	scaffold315	221767	221769	-100	mRNA	218884	229530
P28271	CGI_10001851	0.0	ACOC_MOUSE	reviewed	Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1)	Aco1 Ireb1 Irebp	Mus musculus (Mouse)	889	cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]	3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]	GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539; GO:0070062	CGI_10001851	scaffold36314	20827	20829	100	mRNA	7919	28252
P34056	CGI_10019880	3e-92	AP2A_MOUSE	reviewed	Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2)	Tfap2a Ap2tf Tcfap2a	Mus musculus (Mouse)	437	anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; palate development [GO:0060021]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]	chromatin binding [GO:0003682]; core promoter proximal region sequence-specific DNA binding [GO:0000987]; protein dimerization activity [GO:0046983]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription corepressor activity [GO:0001106]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; transcription coactivator activity [GO:0003713]; transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0000982]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; core promoter proximal region sequence-specific DNA binding [GO:0000987]; protein dimerization activity [GO:0046983]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription corepressor activity [GO:0001106]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0000982]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; palate development [GO:0060021]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559]	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000980; GO:0000981; GO:0000982; GO:0000987; GO:0001077; GO:0001078; GO:0001105; GO:0001106; GO:0001228; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005813; GO:0005829; GO:0006355; GO:0006357; GO:0007399; GO:0007423; GO:0007605; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010944; GO:0014032; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030335; GO:0030501; GO:0035115; GO:0035136; GO:0042059; GO:0042472; GO:0043066; GO:0043231; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0044212; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:2000378	CGI_10019880	scaffold1512	594692	594694	-100	mRNA	584068	595193
P35285	CGI_10020438	5e-65	RB22A_MOUSE	reviewed	Ras-related protein Rab-22A (Rab-22) (Rab-14)	Rab22a Rab22	Mus musculus (Mouse)	194	endocytosis [GO:0006897]; endosome organization [GO:0007032]; protein transport [GO:0015031]; regulation of vesicle size [GO:0097494]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; protein transport [GO:0015031]; regulation of vesicle size [GO:0097494]	GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005886; GO:0006897; GO:0007032; GO:0010008; GO:0015031; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0070062; GO:0097494	CGI_10020438	scaffold315	585285	585287	-100	mRNA	582084	585519
P35398	CGI_10007708	2e-29	RORA_HUMAN	reviewed	Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)	RORA NR1F1 RZRA	Homo sapiens (Human)	523	angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to sterol [GO:0036315]; cellular response to tumor necrosis factor [GO:0071356]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell differentiation [GO:0021702]; cGMP metabolic process [GO:0046068]; circadian regulation of gene expression [GO:0032922]; intracellular receptor signaling pathway [GO:0030522]; muscle cell differentiation [GO:0042692]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cholesterol homeostasis [GO:2000188]; regulation of glucose metabolic process [GO:0010906]; regulation of macrophage activation [GO:0043030]; regulation of smoothened signaling pathway [GO:0008589]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in cell fate commitment [GO:0060850]; T-helper 17 cell differentiation [GO:0072539]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	beta-catenin binding [GO:0008013]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; oxysterol binding [GO:0008142]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; transcription factor activity, direct ligand regulated sequence-specific DNA binding [GO:0098531]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; oxysterol binding [GO:0008142]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; transcription factor activity, direct ligand regulated sequence-specific DNA binding [GO:0098531]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to sterol [GO:0036315]; cellular response to tumor necrosis factor [GO:0071356]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell differentiation [GO:0021702]; cGMP metabolic process [GO:0046068]; circadian regulation of gene expression [GO:0032922]; intracellular receptor signaling pathway [GO:0030522]; muscle cell differentiation [GO:0042692]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cholesterol homeostasis [GO:2000188]; regulation of glucose metabolic process [GO:0010906]; regulation of macrophage activation [GO:0043030]; regulation of smoothened signaling pathway [GO:0008589]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription involved in cell fate commitment [GO:0060850]; regulation of transcription, DNA-templated [GO:0006355]; T-helper 17 cell differentiation [GO:0072539]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]	GO:0000977; GO:0001046; GO:0001222; GO:0001223; GO:0001525; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006367; GO:0006805; GO:0006809; GO:0008013; GO:0008134; GO:0008142; GO:0008270; GO:0008589; GO:0010575; GO:0010906; GO:0019218; GO:0021702; GO:0021930; GO:0030522; GO:0032922; GO:0036315; GO:0042692; GO:0042753; GO:0043030; GO:0043124; GO:0043565; GO:0045599; GO:0045893; GO:0045944; GO:0046068; GO:0050728; GO:0060850; GO:0070328; GO:0071347; GO:0071356; GO:0071456; GO:0072539; GO:0098531; GO:2000188	CGI_10007708	scaffold42776	63696	63698	100	mRNA	61897	67332
P35626	CGI_10010914	0.0	ARBK2_HUMAN	reviewed	Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3)	GRK3 ADRBK2 BARK2	Homo sapiens (Human)	688	receptor internalization [GO:0031623]; signal transduction [GO:0007165]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G-protein coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G-protein coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0007165; GO:0031623; GO:0047696	CGI_10010914	scaffold1288	104654	104656	100	mRNA	77588	105488
P38942	CGI_10010890	3e-109	CAT2_CLOK5	reviewed	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	cat2 CKL_3018	Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)	429	acetyl-CoA metabolic process [GO:0006084]		transferase activity [GO:0016740]	transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084]	GO:0006084; GO:0016740	CGI_10010890	scaffold793	32208	32210	-100	mRNA	28215	33981
P42573	CGI_10023240	4e-10	CED3_CAEEL	reviewed	Cell death protein 3 (EC 3.4.22.-) [Cleaved into: Cell death protein 3 subunit 1; Cell death protein 3 subunit 2]	ced-3 C48D1.2	Caenorhabditis elegans	503	actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse disassembly [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]	caspase complex [GO:0008303]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]	caspase complex [GO:0008303]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse disassembly [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]	GO:0004175; GO:0004197; GO:0005737; GO:0005739; GO:0006915; GO:0006919; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0012501; GO:0016020; GO:0016540; GO:0030042; GO:0030155; GO:0030163; GO:0042802; GO:0043025; GO:0043525; GO:0048471; GO:0097194; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845	CGI_10023240	scaffold408	448158	448160	-100	mRNA	447990	449820
P42765	CGI_10002160	3e-168	THIM_HUMAN	reviewed	3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)	ACAA2	Homo sapiens (Human)	397	cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acyltransferase activity [GO:0003988]; RNA binding [GO:0003723]	extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	GO:0003723; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0006695; GO:0070062; GO:0071456; GO:1901029; GO:1902109	CGI_10002160	scaffold36862	13741	13743	-100	mRNA	12510	18011
P42859	CGI_10028915	0.0	HD_MOUSE	reviewed	Huntingtin (Huntington disease protein homolog) (HD protein homolog)	Htt Hd Hdh	Mus musculus (Mouse)	3119	anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; L-glutamate import [GO:0051938]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of mitophagy [GO:1903599]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297]	autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex [GO:0043234]	beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transcription factor binding [GO:0008134]	autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex [GO:0043234]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; L-glutamate import [GO:0051938]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of mitophagy [GO:1903599]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297]	GO:0000050; GO:0000052; GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006839; GO:0006888; GO:0006890; GO:0006915; GO:0007005; GO:0007029; GO:0007030; GO:0007212; GO:0007283; GO:0007369; GO:0007417; GO:0007420; GO:0007569; GO:0007611; GO:0007612; GO:0007625; GO:0007626; GO:0008088; GO:0008134; GO:0008306; GO:0008340; GO:0008542; GO:0009653; GO:0009952; GO:0016197; GO:0016234; GO:0019244; GO:0019805; GO:0019900; GO:0021756; GO:0021988; GO:0021990; GO:0022008; GO:0030072; GO:0030073; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031410; GO:0031587; GO:0031648; GO:0034452; GO:0034504; GO:0035176; GO:0042297; GO:0042445; GO:0042802; GO:0043065; GO:0043066; GO:0043234; GO:0043524; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0046902; GO:0047496; GO:0048167; GO:0048341; GO:0048471; GO:0048487; GO:0048666; GO:0050809; GO:0051402; GO:0051592; GO:0051881; GO:0051938; GO:0055072; GO:0071539; GO:1901215; GO:1902857; GO:1903599; GO:1904504; GO:1905337; GO:1905505; GO:2001237	CGI_10028915	scaffold22	1435929	1435931	100	mRNA	1433235	1462478
P47989	CGI_10013781	4e-159	XDH_HUMAN	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	XDH XDHA	Homo sapiens (Human)	1333	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115]	cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]	2 iron, 2 sulfur cluster binding [GO:0051537]; electron carrier activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO:0016903]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]	cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron carrier activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO:0016903]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115]	GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006195; GO:0006919; GO:0007595; GO:0009055; GO:0009115; GO:0010629; GO:0016529; GO:0016614; GO:0016903; GO:0042803; GO:0043546; GO:0045602; GO:0050660; GO:0051537; GO:0051898; GO:1900745; GO:1900747; GO:2000379; GO:2001213	CGI_10013781	scaffold1409	74798	74800	100	mRNA	53059	83540
P49139	CGI_10003308	1e-177	MAPK2_RABIT	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) (Fragment)	MAPKAPK2	Oryctolagus cuniculus (Rabbit)	366	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; G2 DNA damage checkpoint [GO:0031572]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; G2 DNA damage checkpoint [GO:0031572]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	GO:0002224; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0006974; GO:0031572; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0044351; GO:0070935	CGI_10003308	scaffold39368	14365	14367	100	mRNA	6519	16111
P49815	CGI_10016453	0.0	TSC2_HUMAN	reviewed	Tuberin (Tuberous sclerosis 2 protein)	TSC2 TSC4	Homo sapiens (Human)	1807	anoikis [GO:0043276]; cell cycle arrest [GO:0007050]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; membrane organization [GO:0061024]; negative regulation of cell proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macromitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]	GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; cell cycle arrest [GO:0007050]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; membrane organization [GO:0061024]; negative regulation of cell proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macromitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007050; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0016020; GO:0016032; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051898; GO:0061024; GO:1901525	CGI_10016453	scaffold756	64524	64526	-100	mRNA	56633	79086
P50429	CGI_10004766	8e-133	ARSB_MOUSE	reviewed	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	Arsb As1 As1-s	Mus musculus (Mouse)	534	colon epithelial cell migration [GO:0061580]; metabolic process [GO:0008152]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; colon epithelial cell migration [GO:0061580]; metabolic process [GO:0008152]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]	GO:0003943; GO:0004065; GO:0005764; GO:0008152; GO:0009986; GO:0010632; GO:0010976; GO:0046872; GO:0061580; GO:0070062	CGI_10004766	scaffold1107	10167	10169	-100	mRNA	9693	14367
P51947	CGI_10006326	6e-66	CCNH_XENLA	reviewed	Cyclin-H (MO15-associated protein) (p36)	ccnh	Xenopus laevis (African clawed frog)	323	cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	TFIIK complex [GO:0070985]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	TFIIK complex [GO:0070985]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0006351; GO:0006355; GO:0007049; GO:0016538; GO:0070985	CGI_10006326	scaffold42184	4203	4205	100	mRNA	2244	28800
P52590	CGI_10006924	0.0	NU107_RAT	reviewed	Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107) (p105)	Nup107	Rattus norvegicus (Rat)	926	mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]	condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	nucleocytoplasmic transporter activity [GO:0005487]; structural constituent of nuclear pore [GO:0017056]	condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleocytoplasmic transporter activity [GO:0005487]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]	GO:0000777; GO:0000973; GO:0005487; GO:0005643; GO:0006355; GO:0006406; GO:0006606; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292	CGI_10006924	scaffold647	59192	59194	-100	mRNA	50031	60378
P53007	CGI_10002774	3e-102	TXTP_HUMAN	reviewed	Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)	SLC25A1 SLC20A3	Homo sapiens (Human)	311	fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transport [GO:0006843]; mitochondrial transport [GO:0006839]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142]; fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transport [GO:0006843]; mitochondrial transport [GO:0006839]	GO:0005634; GO:0005743; GO:0006094; GO:0006839; GO:0006843; GO:0015137; GO:0015142; GO:0016021; GO:0046949; GO:0070062	CGI_10002774	scaffold466	4797	4799	100	mRNA	177	10344
P55210	CGI_10023427	2e-82	CASP7_HUMAN	reviewed	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	CASP7 MCH3	Homo sapiens (Human)	303	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]	GO:0004197; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0008233; GO:0008234; GO:0008635; GO:0072734; GO:0097194; GO:0097200	CGI_10023427	scaffold625	635111	635113	100	mRNA	630275	636369
P60924	CGI_10013666	7e-25	DELE_RAT	reviewed	Death ligand signal enhancer	Dele	Rattus norvegicus (Rat)	509	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]	mitochondrion [GO:0005739]		mitochondrion [GO:0005739]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]	GO:0005739; GO:0008625; GO:0043281	CGI_10013666	scaffold43868	277022	277024	100	mRNA	272203	278191
P62597	CGI_10004647	7e-43	POTE1_CHICK	reviewed	Protection of telomeres protein 1 (cPot1) (POT1-like telomere end-binding protein)	POT1	Gallus gallus (Chicken)	778	negative regulation of telomerase activity [GO:0051974]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	chromosome, telomeric region [GO:0000781]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]	G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]	chromosome, telomeric region [GO:0000781]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]; negative regulation of telomerase activity [GO:0051974]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	GO:0000723; GO:0000781; GO:0000783; GO:0005654; GO:0007004; GO:0010521; GO:0016233; GO:0032210; GO:0043047; GO:0051974; GO:0098505	CGI_10004647	scaffold1045	80799	80801	100	mRNA	73787	82720
P70207	CGI_10003458	5e-08	PLXA2_MOUSE	reviewed	Plexin-A2 (Plex 2) (Plexin-2)	Plxna2 Kiaa0463	Mus musculus (Mouse)	1894	branchiomotor neuron axon guidance [GO:0021785]; cell surface receptor signaling pathway [GO:0007166]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	semaphorin receptor activity [GO:0017154]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor activity [GO:0017154]; branchiomotor neuron axon guidance [GO:0021785]; cell surface receptor signaling pathway [GO:0007166]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]	GO:0001756; GO:0005886; GO:0005887; GO:0007166; GO:0017154; GO:0021785; GO:0021915; GO:0021935; GO:0030334; GO:0048841; GO:0051642; GO:0060037; GO:0060174; GO:0071526	CGI_10003458	scaffold1847	47553	47555	100	mRNA	41168	49978
P84798	CGI_10006996	7e-14	DPOD3_BOVIN	reviewed	DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66) (p68)	POLD3	Bos taurus (Bovine)	466	DNA repair [GO:0006281]; DNA replication [GO:0006260]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-directed DNA polymerase activity [GO:0003887]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	GO:0003887; GO:0005634; GO:0005737; GO:0006260; GO:0006281	CGI_10006996	scaffold575	45212	45214	-100	mRNA	37754	53476
P91929	CGI_10017598	4e-26	NDUAA_DROME	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)	ND-42 CG6343	Drosophila melanogaster (Fruit fly)	407	mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; regulation of glucose metabolic process [GO:0010906]	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; regulation of glucose metabolic process [GO:0010906]	GO:0003954; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0010906	CGI_10017598	scaffold1670	82557	82559	100	mRNA	76397	86392
P97852	CGI_10024801	0.0	DHB4_RAT	reviewed	Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]	Hsd17b4 Edh17b4	Rattus norvegicus (Rat)	735	aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]	peroxisome [GO:0005777]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]	peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]	GO:0004303; GO:0005777; GO:0006635; GO:0007568; GO:0008203; GO:0014070; GO:0016853; GO:0018812; GO:0030283; GO:0033989; GO:0042493; GO:0042803; GO:0044594; GO:0048545; GO:0071407	CGI_10024801	scaffold70	905002	905004	-100	mRNA	891379	905203
P97864	CGI_10027004	7e-29	CASP7_MOUSE	reviewed	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	Casp7 Lice2 Mch3	Mus musculus (Mouse)	303	aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]	GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0009411; GO:0016485; GO:0051402; GO:0072734; GO:0097153; GO:0097194; GO:0097200	CGI_10027004	scaffold471	123609	123611	100	mRNA	121206	125454
Q00174	CGI_10026821	0.0	LAMA_DROME	reviewed	Laminin subunit alpha (Laminin A chain)	LanA lamA CG10236	Drosophila melanogaster (Fruit fly)	3712	axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; female meiosis chromosome segregation [GO:0016321]; heart development [GO:0007507]; inter-male aggressive behavior [GO:0002121]; locomotion involved in locomotory behavior [GO:0031987]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of glucose metabolic process [GO:0010906]; startle response [GO:0001964]; substrate adhesion-dependent cell spreading [GO:0034446]	axon [GO:0030424]; basal lamina [GO:0005605]; basement membrane [GO:0005604]; cell junction [GO:0030054]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]	receptor binding [GO:0005102]	axon [GO:0030424]; basal lamina [GO:0005605]; basement membrane [GO:0005604]; cell junction [GO:0030054]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; receptor binding [GO:0005102]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; female meiosis chromosome segregation [GO:0016321]; heart development [GO:0007507]; inter-male aggressive behavior [GO:0002121]; locomotion involved in locomotory behavior [GO:0031987]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of glucose metabolic process [GO:0010906]; startle response [GO:0001964]; substrate adhesion-dependent cell spreading [GO:0034446]	GO:0001964; GO:0002121; GO:0005102; GO:0005604; GO:0005605; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0010906; GO:0016321; GO:0030054; GO:0030155; GO:0030334; GO:0030424; GO:0031987; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0048854	CGI_10026821	scaffold601	312397	312399	100	mRNA	298645	334195
Q01484	CGI_10019530	0.0	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2	Homo sapiens (Human)	3957	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein targeting to plasma membrane [GO:0072661]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; intracellular [GO:0005622]; M band [GO:0031430]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; intracellular [GO:0005622]; M band [GO:0031430]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein targeting to plasma membrane [GO:0072661]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	GO:0002027; GO:0003283; GO:0005200; GO:0005622; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0072661; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001259	CGI_10019530	scaffold1763	175230	175232	100	mRNA	163532	213844
Q01518	CGI_10022483	2e-118	CAP1_HUMAN	reviewed	Adenylyl cyclase-associated protein 1 (CAP 1)	CAP1 CAP	Homo sapiens (Human)	475	actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]	azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]	azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]	GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005615; GO:0005886; GO:0005925; GO:0006898; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0030864; GO:0035578; GO:0043312; GO:0070062	CGI_10022483	scaffold1021	65344	65346	100	mRNA	61697	98005
Q01831	CGI_10002688	2e-26	XPC_HUMAN	reviewed	DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125)	XPC XPCC	Homo sapiens (Human)	940	DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; intra-S DNA damage checkpoint [GO:0031573]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to drug [GO:0042493]; response to UV-B [GO:0010224]; UV-damage excision repair [GO:0070914]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; XPC complex [GO:0071942]	bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; heteroduplex DNA loop binding [GO:0000404]; single-stranded DNA binding [GO:0003697]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; XPC complex [GO:0071942]; bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; heteroduplex DNA loop binding [GO:0000404]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; intra-S DNA damage checkpoint [GO:0031573]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to drug [GO:0042493]; response to UV-B [GO:0010224]; UV-damage excision repair [GO:0070914]	GO:0000111; GO:0000404; GO:0000405; GO:0000715; GO:0000717; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005886; GO:0006281; GO:0006289; GO:0006294; GO:0006298; GO:0010224; GO:0010996; GO:0031573; GO:0042493; GO:0043231; GO:0070062; GO:0070911; GO:0070914; GO:0071942; GO:1901990	CGI_10002688	scaffold38256	51289	51291	-100	mRNA	46750	52983
Q06441	CGI_10013991	2e-155	TSP4_XENLA	reviewed	Thrombospondin-4	thbs4 tsp4	Xenopus laevis (African clawed frog)	955	cell adhesion [GO:0007155]; positive regulation of cell division [GO:0051781]; response to unfolded protein [GO:0006986]	endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; sarcoplasmic reticulum [GO:0016529]	calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]	endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; cell adhesion [GO:0007155]; positive regulation of cell division [GO:0051781]; response to unfolded protein [GO:0006986]	GO:0005509; GO:0005578; GO:0005615; GO:0005783; GO:0006986; GO:0007155; GO:0008083; GO:0016529; GO:0031012; GO:0051781	CGI_10013991	scaffold43920	92057	92059	100	mRNA	87156	124802
Q08DZ8	CGI_10001721	2e-15	PRIPO_BOVIN	reviewed	DNA-directed primase/polymerase protein (EC 2.7.7.-) (Coiled-coil domain-containing protein 111)	PRIMPOL CCDC111	Bos taurus (Bovine)	555	mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA primase activity [GO:0003896]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005759; GO:0006264; GO:0009411; GO:0019985; GO:0031297	CGI_10001721	scaffold36006	22507	22509	100	mRNA	1062	28962
Q09621	CGI_10004573	2e-56	LACT2_CAEEL	reviewed	Beta-lactamase domain-containing protein 2	lact-2 ZK945.1	Caenorhabditis elegans	473		integral component of membrane [GO:0016021]		integral component of membrane [GO:0016021]	GO:0016021	CGI_10004573	scaffold40916	62873	62875	100	mRNA	60374	63069
Q09LZ8	CGI_10025432	0.0	CBPC6_MOUSE	reviewed	Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4)	Agbl4 Ccp6	Mus musculus (Mouse)	540	C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]	GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0015631; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607	CGI_10025432	scaffold1423	581894	581896	-100	mRNA	578376	592213
Q12996	CGI_10006975	0.0	CSTF3_HUMAN	reviewed	Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77)	CSTF3	Homo sapiens (Human)	717	mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006369; GO:0006378; GO:0006379; GO:0031124	CGI_10006975	scaffold42486	17395	17397	100	mRNA	13709	48840
Q13042	CGI_10020208	0.0	CDC16_HUMAN	reviewed	Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)	CDC16 ANAPC6	Homo sapiens (Human)	620	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cell proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic nuclear division [GO:0007088]; regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051439]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cell proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic nuclear division [GO:0007088]; regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051439]	GO:0000278; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007088; GO:0008283; GO:0031145; GO:0042787; GO:0043161; GO:0051301; GO:0051436; GO:0051437; GO:0051439; GO:0070979	CGI_10020208	scaffold1857	374225	374227	-100	mRNA	371480	383250
Q13136	CGI_10015818	0.0	LIPA1_HUMAN	reviewed	Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)	PPFIA1 LIP1	Homo sapiens (Human)	1202	cell-matrix adhesion [GO:0007160]; glutamate secretion [GO:0014047]; negative regulation of establishment of protein localization to plasma membrane [GO:0090005]; negative regulation of stress fiber assembly [GO:0051497]; neurotransmitter secretion [GO:0007269]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]	signal transducer activity [GO:0004871]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; signal transducer activity [GO:0004871]; cell-matrix adhesion [GO:0007160]; glutamate secretion [GO:0014047]; negative regulation of establishment of protein localization to plasma membrane [GO:0090005]; negative regulation of stress fiber assembly [GO:0051497]; neurotransmitter secretion [GO:0007269]; signal transduction [GO:0007165]	GO:0004871; GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0007269; GO:0014047; GO:0048786; GO:0051497; GO:0090005	CGI_10015818	scaffold227	187559	187561	100	mRNA	179812	199193
Q13490	CGI_10005392	2e-44	BIRC2_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)	BIRC2 API1 MIHB RNF48	Homo sapiens (Human)	618	cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein complex [GO:0043234]; XY body [GO:0001741]	chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein complex [GO:0043234]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0010803; GO:0016579; GO:0016740; GO:0033209; GO:0034121; GO:0035631; GO:0035666; GO:0038061; GO:0039535; GO:0042127; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0043234; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0070266; GO:0070424; GO:0097194; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1990001; GO:2000116; GO:2000377	CGI_10005392	scaffold41656	100483	100485	-100	mRNA	98808	100588
Q14186	CGI_10012373	1e-104	TFDP1_HUMAN	reviewed	Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1)	TFDP1 DP1	Homo sapiens (Human)	410	anoikis [GO:0043276]; cell proliferation [GO:0008283]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]	DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; cell proliferation [GO:0008283]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]	GO:0000083; GO:0000981; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006351; GO:0006357; GO:0006977; GO:0008134; GO:0008283; GO:0008544; GO:0019904; GO:0043276; GO:0045944; GO:0070345; GO:1900740; GO:2000278	CGI_10012373	scaffold43782	274316	274318	100	mRNA	262881	275772
Q14202	CGI_10012126	3e-85	ZMYM3_HUMAN	reviewed	Zinc finger MYM-type protein 3 (Zinc finger protein 261)	ZMYM3 DXS6673E KIAA0385 ZNF261	Homo sapiens (Human)	1370	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0007010; GO:0007275; GO:0008270; GO:0022604	CGI_10012126	scaffold1890	109474	109476	100	mRNA	98892	116547
Q14527	CGI_10013442	0.0	HLTF_HUMAN	reviewed	Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)	HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1	Homo sapiens (Human)	1009	covalent chromatin modification [GO:0016569]; postreplication repair [GO:0006301]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; covalent chromatin modification [GO:0016569]; postreplication repair [GO:0006301]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]	GO:0000209; GO:0000978; GO:0001077; GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006301; GO:0006355; GO:0008270; GO:0016020; GO:0016567; GO:0016569; GO:0016887; GO:0031625; GO:0061630	CGI_10013442	scaffold888	71465	71467	100	mRNA	66885	80306
Q14690	CGI_10025541	1e-122	RRP5_HUMAN	reviewed	Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11)	PDCD11 KIAA0185	Homo sapiens (Human)	1871	maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]	GO:0000462; GO:0000466; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0008134; GO:0032040	CGI_10025541	scaffold370	420529	420531	-100	mRNA	412234	431055
Q15369	CGI_10000789	5e-37	ELOC_HUMAN	reviewed	Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1)	ELOC TCEB1	Homo sapiens (Human)	112	positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]; viral process [GO:0016032]	cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]		cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]; viral process [GO:0016032]	GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0006368; GO:0016032; GO:0016567; GO:0032968; GO:0042787; GO:0043687; GO:0061418; GO:0070449	CGI_10000789	scaffold475	8452	8454	100	mRNA	4744	9923
Q15392	CGI_10021243	0.0	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; tissue development [GO:0009888]	GO:0000139; GO:0000246; GO:0005634; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016614; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0050660; GO:0055114; GO:0061024; GO:1901214	CGI_10021243	scaffold157	293155	293157	100	mRNA	291635	298725
Q15811	CGI_10027282	2e-18	ITSN1_HUMAN	reviewed	Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17)	ITSN1 ITSN SH3D1A	Homo sapiens (Human)	1721	ephrin receptor signaling pathway [GO:0048013]; membrane organization [GO:0061024]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; proline-rich region binding [GO:0070064]; protein complex scaffold [GO:0032947]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; proline-rich region binding [GO:0070064]; protein complex scaffold [GO:0032947]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; ephrin receptor signaling pathway [GO:0048013]; membrane organization [GO:0061024]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]	GO:0005085; GO:0005089; GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0007264; GO:0016032; GO:0019209; GO:0030027; GO:0030054; GO:0030139; GO:0032947; GO:0035023; GO:0043005; GO:0043065; GO:0043524; GO:0045202; GO:0048013; GO:0048488; GO:0051056; GO:0051897; GO:0061024; GO:0070064	CGI_10027282	scaffold3	223880	223882	-100	mRNA	219311	230407
Q16956	CGI_10008834	4e-122	GRP78_APLCA	reviewed	78 kDa glucose-regulated protein (GRP-78) (BiP) (Protein 1603)		Aplysia californica (California sea hare)	667		endoplasmic reticulum lumen [GO:0005788]	ATP binding [GO:0005524]	endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]	GO:0005524; GO:0005788	CGI_10008834	scaffold43108	15179	15181	100	mRNA	5785	21996
Q17LW0	CGI_10016431	0.0	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	GO:0003774; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800	CGI_10016431	scaffold1241	259570	259572	100	mRNA	230364	272061
Q1LY77	CGI_10013795	2e-28	SE1BA_DANRE	reviewed	Histone-lysine N-methyltransferase SETD1B-A (EC 2.1.1.43) (SET domain-containing protein 1B-A)	setd1ba setd1b si:dkey-237o15.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1844	hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	chromosome [GO:0005694]; nuclear speck [GO:0016607]	histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0002244; GO:0003723; GO:0005694; GO:0006351; GO:0006355; GO:0016607; GO:0018024	CGI_10013795	scaffold1409	365016	365018	100	mRNA	360833	368643
Q20930	CGI_10027133	2e-15	MIG17_CAEEL	reviewed	ADAM family mig-17 (EC 3.4.24.-) (A disintegrin and metalloproteinase mig-17) (Abnormal cell migration protein 17)	mig-17 F57B7.4	Caenorhabditis elegans	509	gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]	basement membrane [GO:0005604]; extracellular space [GO:0005615]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]	GO:0004222; GO:0005604; GO:0005615; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	CGI_10027133	scaffold1599	123482	123484	-100	mRNA	123071	130934
Q24307	CGI_10012324	4e-13	DIAP2_DROME	reviewed	Death-associated inhibitor of apoptosis 2 (EC 6.3.2.-) (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2)	Diap2 DIHA Iap2 Ilp CG8293	Drosophila melanogaster (Fruit fly)	498	defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein import into nucleus, translocation [GO:0033160]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of signal transduction [GO:0009966]; sensory organ development [GO:0007423]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ligase activity [GO:0016874]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ligase activity [GO:0016874]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein import into nucleus, translocation [GO:0033160]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of signal transduction [GO:0009966]; sensory organ development [GO:0007423]	GO:0005634; GO:0006964; GO:0007423; GO:0008270; GO:0009966; GO:0016567; GO:0016874; GO:0031625; GO:0033160; GO:0042787; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001	CGI_10012324	scaffold1125	48049	48051	100	mRNA	47884	50397
Q24498	CGI_10025234	0.0	RYR_DROME	reviewed	Ryanodine receptor (Ryanodine receptor 44F)	RyR dry Rya-r44F CG10844	Drosophila melanogaster (Fruit fly)	5127	calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; response to anesthetic [GO:0072347]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]	calcium ion binding [GO:0005509]; ryanodine-sensitive calcium-release channel activity [GO:0005219]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; response to anesthetic [GO:0072347]	GO:0005219; GO:0005509; GO:0005886; GO:0006816; GO:0006936; GO:0007275; GO:0016021; GO:0033017; GO:0035206; GO:0060047; GO:0072347	CGI_10025234	scaffold885	1026228	1026230	100	mRNA	1005329	1048267
Q27954	CGI_10027347	0.0	COPA_BOVIN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Bos taurus (Bovine)	1224	ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]	COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]	hormone activity [GO:0005179]; structural molecule activity [GO:0005198]	COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]	GO:0000139; GO:0005179; GO:0005198; GO:0005576; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126	CGI_10027347	scaffold1179	184426	184428	100	mRNA	178919	200008
Q28FX0	CGI_10018933	2e-72	ELAV3_XENTR	reviewed	ELAV-like protein 3 (Protein ElrC)	elavl3 elrC TGas116i13.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	343	cell differentiation [GO:0030154]; nervous system development [GO:0007399]	intracellular ribonucleoprotein complex [GO:0030529]	RNA binding [GO:0003723]	intracellular ribonucleoprotein complex [GO:0030529]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	GO:0003723; GO:0007399; GO:0030154; GO:0030529	CGI_10018933	scaffold1262	141655	141657	100	mRNA	128637	152422
Q28H54	CGI_10012169	2e-119	CEPT1_XENTR	reviewed	Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2)	cept1 TEgg057p14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	416	phosphatidylethanolamine biosynthetic process [GO:0006646]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646]	GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0016021; GO:0031965; GO:0046872	CGI_10012169	scaffold1571	128741	128743	100	mRNA	125253	131864
Q29RL9	CGI_10019931	4e-73	TCEA1_BOVIN	reviewed	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1)	TCEA1	Bos taurus (Bovine)	301	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0008270	CGI_10019931	scaffold1788	422793	422795	100	mRNA	420630	426027
Q2KIB5	CGI_10004548	1e-21	VA0E2_BOVIN	reviewed	V-type proton ATPase subunit e 2 (V-ATPase subunit e 2) (Vacuolar proton pump subunit e 2)	ATP6V0E2	Bos taurus (Bovine)	81	ATP hydrolysis coupled proton transport [GO:0015991]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; proton-transporting V-type ATPase, V0 domain [GO:0033179]	proton-transporting ATPase activity, rotational mechanism [GO:0046961]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]	GO:0015991; GO:0016020; GO:0016021; GO:0033179; GO:0046961	CGI_10004548	scaffold40910	86125	86127	-100	mRNA	80831	88229
Q2KIJ2	CGI_10018264	3e-37	MET18_BOVIN	reviewed	Histidine protein methyltransferase 1 homolog (Methyltransferase-like protein 18) (EC 2.1.1.-)	METTL18	Bos taurus (Bovine)	373			methyltransferase activity [GO:0008168]	methyltransferase activity [GO:0008168]	GO:0008168	CGI_10018264	scaffold67	85333	85335	-100	mRNA	72770	90591
Q2KIU7	CGI_10015644	1e-101	RSPH9_BOVIN	reviewed	Radial spoke head protein 9 homolog	RSPH9	Bos taurus (Bovine)	276	axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]	GO:0005737; GO:0005856; GO:0005929; GO:0035082; GO:0044458; GO:0060294	CGI_10015644	scaffold1726	371952	371954	-100	mRNA	370135	372226
Q2PC93	CGI_10022184	0.0	SSPO_CHICK	reviewed	SCO-spondin	SSPO	Gallus gallus (Chicken)	5255	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	extracellular space [GO:0005615]		extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	GO:0005615; GO:0007155; GO:0007399; GO:0030154	CGI_10022184	scaffold880	169591	169593	100	mRNA	160331	179223
Q2T9U5	CGI_10024143	3e-31	REXO5_BOVIN	reviewed	RNA exonuclease 5 (EC 3.1.-.-) (Putative RNA exonuclease NEF-sp)	REXO5	Bos taurus (Bovine)	783		extracellular exosome [GO:0070062]; nucleolus [GO:0005730]	exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	GO:0003723; GO:0004527; GO:0005730; GO:0070062	CGI_10024143	scaffold485	113346	113348	100	mRNA	108071	115562
Q32NG5	CGI_10020327	4e-99	GTR12_XENLA	reviewed	Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)	slc2a12 glut12	Xenopus laevis (African clawed frog)	588	carbohydrate transport [GO:0008643]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]	substrate-specific transmembrane transporter activity [GO:0022891]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; substrate-specific transmembrane transporter activity [GO:0022891]; carbohydrate transport [GO:0008643]	GO:0008643; GO:0012505; GO:0016021; GO:0022891	CGI_10020327	scaffold522	357974	357976	-100	mRNA	353330	368188
Q32NQ8	CGI_10001223	3e-75	RNF10_XENLA	reviewed	RING finger protein 10	rnf10	Xenopus laevis (African clawed frog)	756	negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]	GO:0005634; GO:0005737; GO:0006351; GO:0010626; GO:0031643; GO:0044212; GO:0045944; GO:0046872	CGI_10001223	C34158	8559	8561	100	mRNA	8394	13250
Q32PI8	CGI_10027880	7e-18	RT27_BOVIN	reviewed	28S ribosomal protein S27, mitochondrial (MRP-S27) (S27mt)	MRPS27	Bos taurus (Bovine)	415	mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]		mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]	GO:0005743; GO:0005763; GO:0070124; GO:0070125	CGI_10027880	scaffold257	105186	105188	100	mRNA	101851	109887
Q39575	CGI_10024919	6e-173	DYHG_CHLRE	reviewed	Dynein gamma chain, flagellar outer arm	ODA2 ODA-2	Chlamydomonas reinhardtii (Chlamydomonas smithii)	4485	cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0016887; GO:0030286; GO:0031514; GO:0036158; GO:0060294	CGI_10024919	scaffold146	693118	693120	-100	mRNA	671163	748128
Q3HNM7	CGI_10006374	8e-100	INSC_MOUSE	reviewed	Protein inscuteable homolog (Minsc)	Insc	Mus musculus (Mouse)	579	establishment of mitotic spindle orientation [GO:0000132]; lung epithelial cell differentiation [GO:0060487]; nervous system development [GO:0007399]	apical part of cell [GO:0045177]; cell cortex [GO:0005938]		apical part of cell [GO:0045177]; cell cortex [GO:0005938]; establishment of mitotic spindle orientation [GO:0000132]; lung epithelial cell differentiation [GO:0060487]; nervous system development [GO:0007399]	GO:0000132; GO:0005938; GO:0007399; GO:0045177; GO:0060487	CGI_10006374	scaffold1586	143141	143143	100	mRNA	142424	149427
Q3MHR7	CGI_10018003	1e-150	ARPC2_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)	ARPC2	Bos taurus (Bovine)	300	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell junction [GO:0030054]; cytosol [GO:0005829]; neuron projection [GO:0043005]; synapse [GO:0045202]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	Arp2/3 protein complex [GO:0005885]; cell junction [GO:0030054]; cytosol [GO:0005829]; neuron projection [GO:0043005]; synapse [GO:0045202]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	GO:0005200; GO:0005829; GO:0005885; GO:0030041; GO:0030054; GO:0034314; GO:0043005; GO:0045202; GO:0051015	CGI_10018003	scaffold586	211669	211671	100	mRNA	209993	217988
Q3SWZ4	CGI_10023759	6e-120	EXOS9_BOVIN	reviewed	Exosome complex component RRP45 (Exosome component 9)	EXOSC9	Bos taurus (Bovine)	440	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	AU-rich element binding [GO:0017091]	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; AU-rich element binding [GO:0017091]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]	GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0000467; GO:0005654; GO:0005730; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	CGI_10023759	scaffold1307	434978	434980	100	mRNA	426520	439623
Q3T0J9	CGI_10015344	1e-118	GNL3L_BOVIN	reviewed	Guanine nucleotide-binding protein-like 3-like protein	GNL3L	Bos taurus (Bovine)	575	negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]	GO:0003723; GO:0003924; GO:0005525; GO:0005697; GO:0005730; GO:0005829; GO:0016020; GO:0031397; GO:0031647; GO:0032091; GO:0032211; GO:0033234; GO:0042254; GO:0090073; GO:1904816	CGI_10015344	scaffold1160	55394	55396	100	mRNA	50706	61418
Q3ZBX6	CGI_10008650	2e-51	RM03_BOVIN	reviewed	39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3)	MRPL3	Bos taurus (Bovine)	348	mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]	GO:0003723; GO:0003735; GO:0005743; GO:0005762; GO:0070124; GO:0070125	CGI_10008650	scaffold817	7467	7469	100	mRNA	2621	21484
Q498J9	CGI_10008012	4e-49	MBLC1_XENLA	reviewed	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	mblac1	Xenopus laevis (African clawed frog)	233			hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872	CGI_10008012	scaffold42894	17507	17509	-100	mRNA	13782	18002
Q498T3	CGI_10019481	1e-98	ING3_RAT	reviewed	Inhibitor of growth protein 3	Ing3	Rattus norvegicus (Rat)	421	histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	NuA4 histone acetyltransferase complex [GO:0035267]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]	histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	NuA4 histone acetyltransferase complex [GO:0035267]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0000812; GO:0004402; GO:0006351; GO:0006355; GO:0032777; GO:0035064; GO:0035267; GO:0040008; GO:0043065; GO:0043967; GO:0043968; GO:0046872	CGI_10019481	scaffold1322	455783	455785	-100	mRNA	454396	463606
Q4R7X9	CGI_10000485	2e-38	LMBRL_MACFA	reviewed	Protein LMBR1L	LMBR1L QtsA-14131	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	489	endocytosis [GO:0006897]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]	GO:0005886; GO:0006897; GO:0016021	CGI_10000485	C28982	4929	4931	100	mRNA	756	6077
Q4R8M9	CGI_10025273	8e-17	GTSF1_MACFA	reviewed	Gametocyte-specific factor 1 (Protein FAM112B)	GTSF1 FAM112B QtsA-12026	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	167	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	GO:0003676; GO:0005737; GO:0007283; GO:0030154; GO:0046872	CGI_10025273	scaffold82	830825	830827	100	mRNA	828796	842788
Q4V348	CGI_10023537	6e-49	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872	CGI_10023537	scaffold383	350174	350176	100	mRNA	346147	369692
Q4V7A9	CGI_10026497	4e-39	K895L_RAT	reviewed	Uncharacterized protein KIAA0895-like	Kiaa0895l	Rattus norvegicus (Rat)	468						CGI_10026497	scaffold156	346165	346167	-100	mRNA	344252	347529
Q504Y3	CGI_10012962	2e-26	ZCPW2_HUMAN	reviewed	Zinc finger CW-type PWWP domain protein 2	ZCWPW2	Homo sapiens (Human)	356			zinc ion binding [GO:0008270]	zinc ion binding [GO:0008270]	GO:0008270	CGI_10012962	scaffold1054	219083	219085	100	mRNA	217090	236210
Q505D1	CGI_10028081	2e-09	ANR28_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	Ankrd28	Mus musculus (Mouse)	1053		nucleoplasm [GO:0005654]		nucleoplasm [GO:0005654]	GO:0005654	CGI_10028081	scaffold337	757486	757488	100	mRNA	757390	759573
Q52KJ8	CGI_10000428	6e-41	MSRB1_RAT	reviewed	Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.-) (Selenoprotein X) (SelX)	Msrb1 Sepx1	Rattus norvegicus (Rat)	116	actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	actin binding [GO:0003779]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]	GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0006979; GO:0030041; GO:0030091; GO:0033743; GO:0045087; GO:0046872	CGI_10000428	scaffold1242	4421	4423	100	mRNA	3925	4806
Q53HV7	CGI_10028697	6e-75	SMUG1_HUMAN	reviewed	Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-)	SMUG1	Homo sapiens (Human)	270	base-excision repair [GO:0006284]; depyrimidination [GO:0045008]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008]	GO:0000703; GO:0003677; GO:0004844; GO:0005654; GO:0005730; GO:0006284; GO:0017065; GO:0019104; GO:0045008	CGI_10028697	scaffold150	1706374	1706376	-100	mRNA	1704021	1706532
Q54X15	CGI_10018110	6e-08	HDA21_DICDI	reviewed	Type-2 histone deacetylase 1 (DdHdaD) (EC 3.5.1.98)	hdaD DDB_G0279267	Dictyostelium discoideum (Slime mold)	1489	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0032041	CGI_10018110	scaffold396	277285	277287	100	mRNA	275893	279020
Q55E58	CGI_10007718	2e-64	PATS1_DICDI	reviewed	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	pats1 DDB_G0269250	Dictyostelium discoideum (Slime mold)	3184	cheating during chimeric sorocarp development [GO:0099139]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]; small GTPase mediated signal transduction [GO:0007264]	actomyosin [GO:0042641]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; signal transducer activity [GO:0004871]	actomyosin [GO:0042641]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; signal transducer activity [GO:0004871]; cheating during chimeric sorocarp development [GO:0099139]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]; small GTPase mediated signal transduction [GO:0007264]	GO:0000281; GO:0004674; GO:0004721; GO:0004871; GO:0005524; GO:0005525; GO:0005737; GO:0006470; GO:0007264; GO:0035556; GO:0042641; GO:0099139	CGI_10007718	scaffold42790	100273	100275	100	mRNA	47227	102130
Q58CU2	CGI_10008780	7e-141	E41L5_BOVIN	reviewed	Band 4.1-like protein 5	EPB41L5	Bos taurus (Bovine)	502	actomyosin structure organization [GO:0031032]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]	GO:0005200; GO:0005737; GO:0005856; GO:0005912; GO:0008092; GO:0031032	CGI_10008780	scaffold110	147528	147530	100	mRNA	129432	174946
Q5F339	CGI_10004088	5e-94	CCHL_CHICK	reviewed	Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase)	HCCS RCJMB04_37l21	Gallus gallus (Chicken)	273	cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	CGI_10004088	scaffold40456	40313	40315	100	mRNA	27553	45443
Q5H8A4	CGI_10023492	4e-143	PIGG_HUMAN	reviewed	GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G)	PIGG GPI7 UNQ1930/PRO4405	Homo sapiens (Human)	983	GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]	GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267	CGI_10023492	scaffold1258	236457	236459	100	mRNA	227138	243984
Q5M7P5	CGI_10019899	0.0	NOL6_XENTR	reviewed	Nucleolar protein 6	nol6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1145	rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]	CURI complex [GO:0032545]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]	RNA binding [GO:0003723]	CURI complex [GO:0032545]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]	GO:0003723; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456	CGI_10019899	scaffold730	454564	454566	100	mRNA	428381	455185
Q5QQ53	CGI_10002413	0.0	XYLT_DROPS	reviewed	Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase)	oxt xt GA16815	Drosophila pseudoobscura pseudoobscura (Fruit fly)	880	chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	acetylglucosaminyltransferase activity [GO:0008375]; protein xylosyltransferase activity [GO:0030158]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]	GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0050650	CGI_10002413	scaffold857	20029	20031	100	mRNA	9995	21199
Q5QQ53	CGI_10002414	3e-23	XYLT_DROPS	reviewed	Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase)	oxt xt GA16815	Drosophila pseudoobscura pseudoobscura (Fruit fly)	880	chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	acetylglucosaminyltransferase activity [GO:0008375]; protein xylosyltransferase activity [GO:0030158]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]	GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0050650	CGI_10002414	scaffold857	20029	20031	100	mRNA	17815	33794
Q5R9C1	CGI_10022832	0.0	F263_PONAB	reviewed	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]	PFKFB3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	514	fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]		6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]	6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]	GO:0003873; GO:0004331; GO:0005524; GO:0006000; GO:0006003	CGI_10022832	scaffold896	82636	82638	-100	mRNA	79994	116374
Q5R9H4	CGI_10020806	0.0	A1CF_PONAB	reviewed	APOBEC1 complementation factor (APOBEC1-stimulating protein)	A1CF ACF	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	587	mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821]	apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]	single-stranded RNA binding [GO:0003727]	apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821]	GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0016556; GO:0030895; GO:0050821	CGI_10020806	scaffold321	318842	318844	100	mRNA	296753	336591
Q5RA62	CGI_10014259	0.0	ERCC3_PONAB	reviewed	TFIIH basal transcription factor complex helicase XPB subunit (EC 3.6.4.12) (DNA excision repair protein ERCC-3)	ERCC3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	782	apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	holo TFIIH complex [GO:0005675]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]	holo TFIIH complex [GO:0005675]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]	GO:0000717; GO:0003677; GO:0004003; GO:0005524; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006468; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0009411; GO:0016887; GO:0033683; GO:0035315; GO:0043138; GO:0045944; GO:0047485; GO:1901990	CGI_10014259	scaffold1838	291656	291658	-100	mRNA	286604	292555
Q5RB35	CGI_10010809	0.0	MKLN1_PONAB	reviewed	Muskelin	MKLN1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	735	actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]	cell cortex [GO:0005938]; cytosol [GO:0005829]; ruffle [GO:0001726]		cell cortex [GO:0005938]; cytosol [GO:0005829]; ruffle [GO:0001726]; actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]	GO:0001726; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0031532	CGI_10010809	scaffold1753	224100	224102	100	mRNA	214334	228259
Q5RBL1	CGI_10008716	0.0	GARS_PONAB	reviewed	Glycine--tRNA ligase (EC 3.6.1.17) (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (AP-4-A synthetase) (Glycyl-tRNA synthetase) (GlyRS)	GARS	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	739	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]	axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]	axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0006426; GO:0015966; GO:0030424; GO:0046983; GO:0070062	CGI_10008716	scaffold500	94133	94135	100	mRNA	87364	97102
Q5RBN9	CGI_10015640	3e-93	TAD2B_PONAB	reviewed	Transcriptional adapter 2-beta	TADA2B	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	420	regulation of histone acetylation [GO:0035065]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; regulation of histone acetylation [GO:0035065]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0003713; GO:0005634; GO:0006351; GO:0006357; GO:0008270; GO:0035065	CGI_10015640	scaffold1726	339151	339153	100	mRNA	335480	341189
Q5RD33	CGI_10018734	1e-25	APBA2_PONAB	reviewed	Amyloid beta A4 precursor protein-binding family A member 2	APBA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	749	chemical synaptic transmission [GO:0007268]; protein transport [GO:0015031]	synaptic vesicle [GO:0008021]	beta-amyloid binding [GO:0001540]	synaptic vesicle [GO:0008021]; beta-amyloid binding [GO:0001540]; chemical synaptic transmission [GO:0007268]; protein transport [GO:0015031]	GO:0001540; GO:0007268; GO:0008021; GO:0015031	CGI_10018734	scaffold1123	230201	230203	-100	mRNA	218721	230417
Q5REU4	CGI_10026535	0.0	SND1_PONAB	reviewed	Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (p100 co-activator)	SND1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	910	gene silencing by RNA [GO:0031047]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	melanosome [GO:0042470]; nucleus [GO:0005634]; RISC complex [GO:0016442]	nuclease activity [GO:0004518]; nucleic acid binding [GO:0003676]	melanosome [GO:0042470]; nucleus [GO:0005634]; RISC complex [GO:0016442]; nuclease activity [GO:0004518]; nucleic acid binding [GO:0003676]; gene silencing by RNA [GO:0031047]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003676; GO:0004518; GO:0005634; GO:0006351; GO:0006355; GO:0016442; GO:0031047; GO:0042470	CGI_10026535	scaffold156	962561	962563	-100	mRNA	933214	963088
Q5RFA0	CGI_10025645	0.0	NELFD_PONAB	reviewed	Negative elongation factor D (NELF-D) (TH1-like protein)	NELFCD NELFD TH1L	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	590	negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	RNA binding [GO:0003723]	nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]	GO:0003723; GO:0005634; GO:0006351; GO:0045892	CGI_10025645	scaffold121	369487	369489	-100	mRNA	363883	377276
Q5RG45	CGI_10015025	4e-174	CP135_DANRE	reviewed	Centrosomal protein of 135 kDa (Cep135)	cep135 si:dkeyp-117h8.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1164	centriole-centriole cohesion [GO:0010457]; centriole replication [GO:0007099]	centriole [GO:0005814]		centriole [GO:0005814]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]	GO:0005814; GO:0007099; GO:0010457	CGI_10015025	scaffold43986	139098	139100	-100	mRNA	136367	147133
Q5RGJ8	CGI_10013374	0.0	GNPTA_DANRE	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	gnptab gnpta si:ch211-234f20.3 zgc:122985	Danio rerio (Zebrafish) (Brachydanio rerio)	1219	bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]	GO:0000139; GO:0002063; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348	CGI_10013374	scaffold1804	202383	202385	100	mRNA	193730	212178
Q5T1B0	CGI_10007458	3e-147	AXDN1_HUMAN	reviewed	Axonemal dynein light chain domain-containing protein 1	AXDND1 C1orf125	Homo sapiens (Human)	1012						CGI_10007458	scaffold42662	93141	93143	-100	mRNA	68883	113325
Q5T3U5	CGI_10016527	0.0	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	transmembrane transport [GO:0055085]	integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATPase-coupled anion transmembrane transporter activity [GO:0043225]; ATP binding [GO:0005524]	integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATPase-coupled anion transmembrane transporter activity [GO:0043225]; transmembrane transport [GO:0055085]	GO:0005524; GO:0005765; GO:0005886; GO:0005887; GO:0042626; GO:0043225; GO:0055085	CGI_10016527	scaffold1083	126870	126872	-100	mRNA	123062	132804
Q5TB80	CGI_10013098	7e-106	CE162_HUMAN	reviewed	Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog)	CEP162 C6orf84 KIAA1009 QN1	Homo sapiens (Human)	1403	ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]		axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]	GO:0005634; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0060271; GO:0097711	CGI_10013098	scaffold43842	93062	93064	100	mRNA	72885	97760
Q5U550	CGI_10009056	2e-27	DDA1_XENLA	reviewed	DET1- and DDB1-associated protein 1	dda1	Xenopus laevis (African clawed frog)	101	regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]			regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	GO:0032434	CGI_10009056	scaffold916	39259	39261	-100	mRNA	33463	44191
Q5W0Z9	CGI_10006703	2e-113	ZDH20_HUMAN	reviewed	Probable palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 20) (DHHC-20)	ZDHHC20	Homo sapiens (Human)	365	protein palmitoylation [GO:0018345]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein palmitoylation [GO:0018345]	GO:0005886; GO:0016020; GO:0016021; GO:0016409; GO:0018345; GO:0019706	CGI_10006703	scaffold42366	119281	119283	100	mRNA	116419	123857
Q5ZM35	CGI_10008613	1e-118	TWF2_CHICK	reviewed	Twinfilin-2	TWF2 RCJMB04_3e19	Gallus gallus (Chicken)	349	negative regulation of actin filament polymerization [GO:0030837]	cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]	cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; negative regulation of actin filament polymerization [GO:0030837]	GO:0003779; GO:0005856; GO:0030837; GO:0048471	CGI_10008613	scaffold743	78323	78325	100	mRNA	78257	83384
Q60HD5	CGI_10006854	3e-74	PPOX_MACFA	reviewed	Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4)	PPOX QccE-13968	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	477	heme biosynthetic process [GO:0006783]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]	intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial membrane [GO:0031966]	oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]	intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial membrane [GO:0031966]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]	GO:0004729; GO:0006779; GO:0006782; GO:0006783; GO:0031304; GO:0031966; GO:0055114	CGI_10006854	scaffold42422	115936	115938	-100	mRNA	114829	123344
Q61124	CGI_10021444	4e-14	CLN3_MOUSE	reviewed	Battenin (Protein CLN3)	Cln3	Mus musculus (Mouse)	438	actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amino acid transport [GO:0006865]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; cell migration [GO:0016477]; cellular amino acid metabolic process [GO:0006520]; ceramide metabolic process [GO:0006672]; endocytosis [GO:0006897]; galactosylceramide metabolic process [GO:0006681]; globoside metabolic process [GO:0001575]; glucosylceramide metabolic process [GO:0006678]; ionotropic glutamate receptor signaling pathway [GO:0035235]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468]; sphingomyelin metabolic process [GO:0006684]; vacuolar transport [GO:0007034]; vesicle transport along microtubule [GO:0047496]	autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]	calcium-dependent protein binding [GO:0048306]	autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; calcium-dependent protein binding [GO:0048306]; actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amino acid transport [GO:0006865]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; cell migration [GO:0016477]; cellular amino acid metabolic process [GO:0006520]; ceramide metabolic process [GO:0006672]; endocytosis [GO:0006897]; galactosylceramide metabolic process [GO:0006681]; globoside metabolic process [GO:0001575]; glucosylceramide metabolic process [GO:0006678]; ionotropic glutamate receptor signaling pathway [GO:0035235]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468]; sphingomyelin metabolic process [GO:0006684]; vacuolar transport [GO:0007034]; vesicle transport along microtubule [GO:0047496]	GO:0000139; GO:0001508; GO:0001575; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005886; GO:0005901; GO:0006520; GO:0006672; GO:0006678; GO:0006681; GO:0006684; GO:0006865; GO:0006897; GO:0006898; GO:0007034; GO:0007040; GO:0007042; GO:0008021; GO:0008306; GO:0010468; GO:0015809; GO:0016021; GO:0016236; GO:0016477; GO:0016485; GO:0030036; GO:0030176; GO:0031410; GO:0035235; GO:0035752; GO:0042133; GO:0042987; GO:0043005; GO:0043066; GO:0043086; GO:0043524; GO:0045121; GO:0045861; GO:0047496; GO:0048306; GO:0050885; GO:0051480; GO:0051489; GO:0061024; GO:0072657; GO:0072659; GO:0097352	CGI_10021444	scaffold664	276272	276274	-100	mRNA	276241	287455
Q61220	CGI_10006105	9e-07	NELL2_MOUSE	reviewed	Protein kinase C-binding protein NELL2 (MEL91 protein) (NEL-like protein 2)	Nell2 Mel91	Mus musculus (Mouse)	819	neuron cellular homeostasis [GO:0070050]	cell [GO:0005623]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	cell [GO:0005623]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; neuron cellular homeostasis [GO:0070050]	GO:0005509; GO:0005576; GO:0005623; GO:0070050	CGI_10006105	scaffold42090	42095	42097	-100	mRNA	40433	47593
Q62915	CGI_10021945	3e-176	CSKP_RAT	reviewed	Peripheral plasma membrane protein CASK (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase)	Cask	Rattus norvegicus (Rat)	909	cerebral cortex development [GO:0021987]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; protein targeting to plasma membrane [GO:0072661]; regulation of transcription from RNA polymerase II promoter [GO:0006357]	apical dendrite [GO:0097440]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein complex [GO:0043234]; synaptic membrane [GO:0097060]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein complex binding [GO:0032403]; protein C-terminus binding [GO:0008022]; protein serine/threonine kinase activity [GO:0004674]	apical dendrite [GO:0097440]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein complex [GO:0043234]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein complex binding [GO:0032403]; protein serine/threonine kinase activity [GO:0004674]; cerebral cortex development [GO:0021987]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; protein targeting to plasma membrane [GO:0072661]; regulation of transcription from RNA polymerase II promoter [GO:0006357]	GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0008022; GO:0014069; GO:0016020; GO:0016323; GO:0021987; GO:0030165; GO:0030425; GO:0032024; GO:0032403; GO:0042043; GO:0042734; GO:0043025; GO:0043234; GO:0045121; GO:0060170; GO:0061003; GO:0072661; GO:0097060; GO:0097440; GO:0098846	CGI_10021945	scaffold1086	399467	399469	-100	mRNA	385000	413907
Q63164	CGI_10026448	0.0	DYH1_RAT	reviewed	Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1)	Dnah1 Dlp1	Rattus norvegicus (Rat)	4516	cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]	cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]	cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]	GO:0003341; GO:0003351; GO:0005524; GO:0005737; GO:0005874; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959; GO:0060294	CGI_10026448	scaffold100	676764	676766	100	mRNA	671285	725122
Q63424	CGI_10009837	9e-88	S15A2_RAT	reviewed	Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)	Slc15a2 Pept2	Rattus norvegicus (Rat)	729	antibiotic transport [GO:0042891]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]	integral component of membrane [GO:0016021]	antibiotic transporter activity [GO:0042895]; dipeptide transporter activity [GO:0042936]; symporter activity [GO:0015293]	integral component of membrane [GO:0016021]; antibiotic transporter activity [GO:0042895]; dipeptide transporter activity [GO:0042936]; symporter activity [GO:0015293]; antibiotic transport [GO:0042891]; dipeptide transport [GO:0042938]; protein transport [GO:0015031]	GO:0015031; GO:0015293; GO:0016021; GO:0042891; GO:0042895; GO:0042936; GO:0042938	CGI_10009837	scaffold43344	111166	111168	100	mRNA	99743	118350
Q6DCP1	CGI_10021842	1e-123	FXRD1_XENLA	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	foxred1	Xenopus laevis (African clawed frog)	499	mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	oxidoreductase activity [GO:0016491]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	CGI_10021842	scaffold1094	672947	672949	-100	mRNA	672347	681488
Q6DFF9	CGI_10022310	0.0	MABP1_XENLA	reviewed	Mitogen-activated protein kinase-binding protein 1	mapkbp1	Xenopus laevis (African clawed frog)	1580						CGI_10022310	scaffold6	314217	314219	-100	mRNA	292176	324328
Q6DFM9	CGI_10024362	1e-40	TOM20_XENTR	reviewed	Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20)	tomm20 TNeu065b24.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	147	mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031]	integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]	mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031]	GO:0005742; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0031307; GO:0070096	CGI_10024362	scaffold1785	161615	161617	100	mRNA	161099	163393
Q6DFV5	CGI_10018402	0.0	HELZ_MOUSE	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-)	Helz Kiaa0054	Mus musculus (Mouse)	1964		membrane [GO:0016020]; nucleus [GO:0005634]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0016020; GO:0046872	CGI_10018402	scaffold1324	504839	504841	100	mRNA	504763	511203
Q6DJI8	CGI_10008836	2e-105	EI3GA_XENLA	reviewed	Eukaryotic translation initiation factor 3 subunit G-A (eIF3g-A) (Eukaryotic translation initiation factor 3 RNA-binding subunit A) (eIF-3 RNA-binding subunit A) (Eukaryotic translation initiation factor 3 subunit 4-A)	eif3g-a eif3s4-a	Xenopus laevis (African clawed frog)	308	translational initiation [GO:0006413]	eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]	GO:0003743; GO:0005852; GO:0006413	CGI_10008836	scaffold43108	34154	34156	-100	mRNA	25539	70737
Q6GPV5	CGI_10002232	2e-16	RN181_XENLA	reviewed	E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) (RING-type E3 ubiquitin transferase RNF181)	rnf181	Xenopus laevis (African clawed frog)	156	protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; transferase activity [GO:0016740]	metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]	GO:0016567; GO:0016740; GO:0046872	CGI_10002232	scaffold37002	20786	20788	100	mRNA	16492	24413
Q6IFY7	CGI_10025479	2e-50	RTN1A_XENLA	reviewed	Reticulon-1-A (RTN1.1) (xRTN1) (XRTN1-C.1)	rtn1-a	Xenopus laevis (African clawed frog)	207		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	GO:0005634; GO:0005789; GO:0016021	CGI_10025479	scaffold1188	465078	465080	100	mRNA	459213	467928
Q6KCD5	CGI_10002811	0.0	NIPBL_MOUSE	reviewed	Nipped-B-like protein (Delangin homolog) (SCC2 homolog)	Nipbl	Mus musculus (Mouse)	2798	brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; developmental growth [GO:0048589]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of ossification [GO:0045778]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038]	chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]	chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; developmental growth [GO:0048589]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of ossification [GO:0045778]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038]	GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008022; GO:0019827; GO:0031065; GO:0032116; GO:0034088; GO:0034613; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045892; GO:0045944; GO:0045995; GO:0047485; GO:0048557; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0070062; GO:0070087; GO:0071481	CGI_10002811	scaffold38510	48976	48978	100	mRNA	16647	55821
Q6NVR9	CGI_10006763	0.0	ATAD3_XENTR	reviewed	ATPase family AAA domain-containing protein 3	atad3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	594		integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]	ATP binding [GO:0005524]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0042645	CGI_10006763	scaffold503	102546	102548	100	mRNA	95147	103207
Q6NXK5	CGI_10019873	9e-36	DUS11_MOUSE	reviewed	RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1)	Dusp11 Pir1	Mus musculus (Mouse)	321	polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]	fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]	fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]	GO:0001650; GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0006470; GO:0008138; GO:0016070; GO:0016607; GO:0016791; GO:0045171; GO:0098507; GO:0098519	CGI_10019873	scaffold1512	497780	497782	-100	mRNA	495502	499794
Q6P1C1	CGI_10015211	8e-42	IPPK_MOUSE	reviewed	Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)	Ippk	Mus musculus (Mouse)	489	inositol phosphate biosynthetic process [GO:0032958]; inositol phosphorylation [GO:0052746]	cytoplasm [GO:0005737]; intracellular [GO:0005622]; nucleus [GO:0005634]	ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]	cytoplasm [GO:0005737]; intracellular [GO:0005622]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphorylation [GO:0052746]	GO:0005524; GO:0005622; GO:0005634; GO:0005737; GO:0032958; GO:0035299; GO:0052746	CGI_10015211	scaffold1665	348569	348571	100	mRNA	314618	349133
Q6P1D7	CGI_10019710	4e-24	SLX4_MOUSE	reviewed	Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12)	Slx4 Btbd12	Mus musculus (Mouse)	1565	DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]	cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]	3'-flap endonuclease activity [GO:0048257]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; enzyme activator activity [GO:0008047]	cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 3'-flap endonuclease activity [GO:0048257]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]	GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0000784; GO:0000790; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0008821; GO:0010792; GO:0017108; GO:0030054; GO:0033557; GO:0036297; GO:0048257; GO:0048476; GO:0061820; GO:0070522; GO:0072429; GO:0090656; GO:1904357; GO:1904431	CGI_10019710	scaffold1031	425965	425967	100	mRNA	399453	444948
Q6P1E7	CGI_10022501	2e-32	PRIPO_MOUSE	reviewed	DNA-directed primase/polymerase protein (EC 2.7.7.-) (Coiled-coil domain-containing protein 111)	Primpol Ccdc111	Mus musculus (Mouse)	537	mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA primase activity [GO:0003896]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005759; GO:0006264; GO:0009411; GO:0019985; GO:0031297	CGI_10022501	scaffold1021	484587	484589	100	mRNA	476874	498131
Q6P9P0	CGI_10023569	7e-14	SLF2_MOUSE	reviewed	SMC5-SMC6 complex localization factor protein 2	Slf2 Fam178a	Mus musculus (Mouse)	1278	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]	chromatin [GO:0000785]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	protein complex binding [GO:0032403]; ubiquitin protein ligase binding [GO:0031625]	chromatin [GO:0000785]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; protein complex binding [GO:0032403]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]	GO:0000785; GO:0005615; GO:0005634; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0032403; GO:0034184; GO:0035861; GO:0043231; GO:1990166; GO:2000781	CGI_10023569	scaffold20	260402	260404	-100	mRNA	255946	279320
Q6PDJ1	CGI_10015774	2e-62	CAHD1_MOUSE	reviewed	VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)	Cachd1 Kiaa1573 Vwcd1	Mus musculus (Mouse)	1288	calcium ion transport [GO:0006816]	integral component of membrane [GO:0016021]		integral component of membrane [GO:0016021]; calcium ion transport [GO:0006816]	GO:0006816; GO:0016021	CGI_10015774	scaffold499	375748	375750	100	mRNA	362994	377463
Q6PEE2	CGI_10011720	2e-39	CTIF_MOUSE	reviewed	CBP80/20-dependent translation initiation factor	Ctif Gm672 Kiaa0427	Mus musculus (Mouse)	600	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	RNA binding [GO:0003723]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]	GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0048471	CGI_10011720	scaffold43664	243507	243509	100	mRNA	241872	245552
Q6YHK3	CGI_10026294	5e-92	CD109_HUMAN	reviewed	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	CD109 CPAMD7	Homo sapiens (Human)	1445	C-terminal protein lipidation [GO:0006501]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; C-terminal protein lipidation [GO:0006501]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0006501; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	CGI_10026294	scaffold1836	556733	556735	-100	mRNA	552352	568475
Q74GW7	CGI_10005980	3e-37	TTCA_GEOSL	reviewed	tRNA 2-thiocytidine biosynthesis protein TtcA	ttcA GSU0127	Geobacter sulfurreducens (strain ATCC 51573 / DSM 12127 / PCA)	257	tRNA processing [GO:0008033]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; tRNA processing [GO:0008033]	GO:0005524; GO:0005737; GO:0008033	CGI_10005980	scaffold1180	50199	50201	-100	mRNA	47029	56801
Q75N73	CGI_10025484	8e-56	S39AE_MOUSE	reviewed	Zinc transporter ZIP14 (Factor for adipocyte differentiation 123) (FAD-123) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)	Slc39a14 Fad123 Kiaa0062 Zip14	Mus musculus (Mouse)	489	cellular zinc ion homeostasis [GO:0006882]; iron ion transport [GO:0006826]; zinc II ion transmembrane import [GO:0071578]; zinc II ion transmembrane transport [GO:0071577]; zinc II ion transport [GO:0006829]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]	ferrous iron transmembrane transporter activity [GO:0015093]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ferrous iron transmembrane transporter activity [GO:0015093]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; iron ion transport [GO:0006826]; zinc II ion transmembrane import [GO:0071578]; zinc II ion transmembrane transport [GO:0071577]; zinc II ion transport [GO:0006829]	GO:0005384; GO:0005385; GO:0005737; GO:0005886; GO:0005887; GO:0006826; GO:0006829; GO:0006882; GO:0015093; GO:0016021; GO:0030027; GO:0071577; GO:0071578	CGI_10025484	scaffold1188	544056	544058	-100	mRNA	524746	544144
Q75QN2	CGI_10017467	7e-158	INT8_HUMAN	reviewed	Integrator complex subunit 8 (Int8) (Protein kaonashi-1)	INTS8 C8orf52	Homo sapiens (Human)	995	snRNA processing [GO:0016180]; snRNA transcription from RNA polymerase II promoter [GO:0042795]	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]		integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; snRNA processing [GO:0016180]; snRNA transcription from RNA polymerase II promoter [GO:0042795]	GO:0005654; GO:0016180; GO:0032039; GO:0042795	CGI_10017467	scaffold1037	367553	367555	-100	mRNA	359042	384651
Q75WF2	CGI_10018880	9e-41	DNA2_ACAPL	reviewed	Plancitoxin-1 (EC 3.1.22.1) (Plancitoxin I) (Plan-I) [Cleaved into: Plancitoxin-1 subunit alpha; Plancitoxin-1 subunit beta]		Acanthaster planci (Crown-of-thorns starfish)	358	apoptotic process [GO:0006915]	extracellular region [GO:0005576]	deoxyribonuclease II activity [GO:0004531]	extracellular region [GO:0005576]; deoxyribonuclease II activity [GO:0004531]; apoptotic process [GO:0006915]	GO:0004531; GO:0005576; GO:0006915	CGI_10018880	scaffold914	210734	210736	-100	mRNA	193050	211566
Q7SY52	CGI_10009786	8e-131	STK10_DANRE	reviewed	Serine/threonine-protein kinase 10 (EC 2.7.11.1)	stk10 zgc:63495	Danio rerio (Zebrafish) (Brachydanio rerio)	974	activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of lymphocyte migration [GO:2000401]; regulation of mitotic cell cycle [GO:0007346]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of lymphocyte migration [GO:2000401]; regulation of mitotic cell cycle [GO:0007346]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0007049; GO:0007346; GO:0023014; GO:0031098; GO:0032147; GO:0042803; GO:0042981; GO:0046777; GO:2000401	CGI_10009786	scaffold43314	222825	222827	100	mRNA	191485	222898
Q7SY73	CGI_10013782	3e-58	ABH6B_XENLA	reviewed	Monoacylglycerol lipase abhd6-B (EC 3.1.1.23) (Abhydrolase domain-containing protein 6-B)	abhd6-b	Xenopus laevis (African clawed frog)	337	acylglycerol catabolic process [GO:0046464]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	acylglycerol lipase activity [GO:0047372]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; acylglycerol lipase activity [GO:0047372]; acylglycerol catabolic process [GO:0046464]	GO:0005739; GO:0016021; GO:0046464; GO:0047372	CGI_10013782	scaffold1409	74798	74800	100	mRNA	72987	87792
Q7TPD0	CGI_10005253	0.0	INT3_MOUSE	reviewed	Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A)	Ints3	Mus musculus (Mouse)	1041	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SOSS complex [GO:0070876]		cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180]	GO:0005634; GO:0005730; GO:0005737; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0016180; GO:0032039; GO:0070876	CGI_10005253	scaffold41588	34400	34402	100	mRNA	26701	37002
Q7ZTY7	CGI_10019642	1e-31	USE1_DANRE	reviewed	Vesicle transport protein USE1 (USE1-like protein)	use1 use1l zgc:56402	Danio rerio (Zebrafish) (Brachydanio rerio)	258	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	GO:0005789; GO:0015031; GO:0016021; GO:0016192	CGI_10019642	scaffold1896	328697	328699	100	mRNA	318066	331623
Q7ZVA6	CGI_10010714	0.0	IF4A3_DANRE	reviewed	Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3)	eif4a3 ddx48	Danio rerio (Zebrafish) (Brachydanio rerio)	406	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]	GO:0000184; GO:0000381; GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0010468; GO:0010501; GO:0016607; GO:0051028; GO:0071013	CGI_10010714	scaffold43520	78962	78964	100	mRNA	78863	95530
Q80U96	CGI_10021125	0.0	XPO1_RAT	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	Xpo1 Crm1	Rattus norvegicus (Rat)	1071	mRNA transport [GO:0051028]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular ribonucleoprotein complex [GO:0030529]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular ribonucleoprotein complex [GO:0030529]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0030529; GO:0031965; GO:0034504; GO:0042176; GO:0042493; GO:0046825; GO:0051028	CGI_10021125	scaffold610	474349	474351	100	mRNA	470294	477844
Q80ZJ7	CGI_10014713	4e-08	SNX32_MOUSE	reviewed	Sorting nexin-32 (Sorting nexin-6B)	Snx32 Snx6b	Mus musculus (Mouse)	404	endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle organization [GO:0016050]	endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]	phosphatidylinositol binding [GO:0035091]	endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle organization [GO:0016050]	GO:0005768; GO:0006897; GO:0015031; GO:0016050; GO:0019898; GO:0035091	CGI_10014713	scaffold659	355954	355956	100	mRNA	350486	357246
Q86UW6	CGI_10028574	1e-40	N4BP2_HUMAN	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	N4BP2 B3BP KIAA1413	Homo sapiens (Human)	1770		cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	GO:0004519; GO:0005524; GO:0005829; GO:0046404	CGI_10028574	scaffold1024	1308344	1308346	100	mRNA	1283549	1309169
Q86WG5	CGI_10026116	0.0	MTMRD_HUMAN	reviewed	Myotubularin-related protein 13 (SET-binding factor 2)	SBF2 CMT4B2 KIAA1766 MTMR13	Homo sapiens (Human)	1849	membrane organization [GO:0061024]; myelination [GO:0042552]; protein tetramerization [GO:0051262]	cytosol [GO:0005829]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]	phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	cytosol [GO:0005829]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; membrane organization [GO:0061024]; myelination [GO:0042552]; protein tetramerization [GO:0051262]	GO:0005774; GO:0005829; GO:0016020; GO:0017112; GO:0019208; GO:0019902; GO:0035091; GO:0042552; GO:0042803; GO:0051262; GO:0061024	CGI_10026116	scaffold204	531365	531367	100	mRNA	515741	537407
Q86WZ0	CGI_10008667	5e-89	HEAT4_HUMAN	reviewed	HEAT repeat-containing protein 4	HEATR4	Homo sapiens (Human)	1026						CGI_10008667	scaffold418	16292	16294	-100	mRNA	4828	18090
Q8AYS7	CGI_10028314	6e-94	CENPI_CHICK	reviewed	Centromere protein I (CENP-I)	CENPI	Gallus gallus (Chicken)	753	centromere complex assembly [GO:0034508]	cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]		cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; centromere complex assembly [GO:0034508]	GO:0000776; GO:0005829; GO:0016604; GO:0034508	CGI_10028314	scaffold1532	1613196	1613198	100	mRNA	1610301	1631386
Q8BFR4	CGI_10028421	4e-159	GNS_MOUSE	reviewed	N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)	Gns	Mus musculus (Mouse)	544	glycosaminoglycan metabolic process [GO:0030203]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]	metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfuric ester hydrolase activity [GO:0008484]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan metabolic process [GO:0030203]	GO:0005764; GO:0008449; GO:0008484; GO:0030203; GO:0046872; GO:0070062	CGI_10028421	scaffold102	110675	110677	-100	mRNA	106910	127626
Q8BGF9	CGI_10011288	8e-29	S2544_MOUSE	reviewed	Solute carrier family 25 member 44	Slc25a44	Mus musculus (Mouse)	314	mitochondrial transport [GO:0006839]	integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	transmembrane transporter activity [GO:0022857]	integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857]; mitochondrial transport [GO:0006839]	GO:0005739; GO:0005743; GO:0006839; GO:0022857; GO:0031307	CGI_10011288	scaffold1821	146021	146023	-100	mRNA	145630	148501
Q8BJ34	CGI_10007033	0.0	MARF1_MOUSE	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1)	Marf1 Kiaa0430 Lkap	Mus musculus (Mouse)	1730	double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]	RNA binding [GO:0003723]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]	GO:0003723; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0010923; GO:0016020; GO:0043231; GO:0048477	CGI_10007033	scaffold42508	140832	140834	100	mRNA	132335	147112
Q8BK67	CGI_10011007	3e-170	RCC2_MOUSE	reviewed	Protein RCC2	Rcc2 Kiaa1470	Mus musculus (Mouse)	520	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]	chromosome, centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	chromosome, centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]	GO:0003723; GO:0005634; GO:0005730; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0048365; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023	CGI_10011007	scaffold308	108209	108211	-100	mRNA	89849	109933
Q8BRH4	CGI_10016397	1e-117	KMT2C_MOUSE	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog)	Kmt2c Mll3	Mus musculus (Mouse)	4903	eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; single fertilization [GO:0007338]; transcription, DNA-templated [GO:0006351]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transferase activity, transferring acyl groups [GO:0016746]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transferase activity, transferring acyl groups [GO:0016746]; eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; single fertilization [GO:0007338]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0007338; GO:0010468; GO:0016571; GO:0016746; GO:0035097; GO:0035264; GO:0042800; GO:0044666; GO:0046872; GO:0048146; GO:0061029	CGI_10016397	scaffold1800	57861	57863	100	mRNA	806	94076
Q8BV79	CGI_10009891	1e-07	TRNK1_MOUSE	reviewed	TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1)	Trank1 Gm187 Kiaa0342 Lba1	Mus musculus (Mouse)	2999						CGI_10009891	scaffold1850	196439	196441	100	mRNA	186003	202663
Q8BW86	CGI_10020669	2e-19	ARG33_MOUSE	reviewed	Rho guanine nucleotide exchange factor 33	Arhgef33 Gm941	Mus musculus (Mouse)	850	regulation of Rho protein signal transduction [GO:0035023]		Rho guanyl-nucleotide exchange factor activity [GO:0005089]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]	GO:0005089; GO:0035023	CGI_10020669	scaffold288	403108	403110	-100	mRNA	398368	420361
Q8BW94	CGI_10004785	0.0	DYH3_MOUSE	reviewed	Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)	Dnah3 Dnahc3	Mus musculus (Mouse)	4083	cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]	cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]	cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959	CGI_10004785	scaffold892	27358	27360	-100	mRNA	11371	52730
Q8BX70	CGI_10026852	6e-151	VP13C_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13C	Vps13c Kiaa3021	Mus musculus (Mouse)	3748	mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]		cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]	GO:0005741; GO:0005829; GO:0007005; GO:0070062; GO:1905090	CGI_10026852	scaffold601	891975	891977	100	mRNA	888551	922212
Q8BYF6	CGI_10013770	6e-112	SC5A8_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	Slc5a8 Smct Smct1	Mus musculus (Mouse)	611	apoptotic process [GO:0006915]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; sodium ion transport [GO:0006814]	GO:0006814; GO:0006915; GO:0015293; GO:0016021; GO:0016324; GO:0070062	CGI_10013770	scaffold510	220645	220647	100	mRNA	219167	237960
Q8BZI6	CGI_10023669	2e-34	GUCD1_MOUSE	reviewed	Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4)	Gucd1	Mus musculus (Mouse)	239						CGI_10023669	scaffold54	238845	238847	100	mRNA	236741	244207
Q8C033	CGI_10027500	5e-105	ARHGA_MOUSE	reviewed	Rho guanine nucleotide exchange factor 10	Arhgef10 Kiaa0294	Mus musculus (Mouse)	1345	activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]	centrosome [GO:0005813]; cytosol [GO:0005829]	kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]	GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630	CGI_10027500	scaffold501	120317	120319	100	mRNA	120151	144291
Q8CDF7	CGI_10021786	2e-38	EXD1_MOUSE	reviewed	piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1)	Exd1 Exdl1	Mus musculus (Mouse)	570	gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]	PET complex [GO:1990923]; P granule [GO:0043186]	protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]	GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:1990923	CGI_10021786	scaffold347	222336	222338	100	mRNA	217866	225837
Q8CFA2	CGI_10019480	1e-154	GCST_MOUSE	reviewed	Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)	Amt	Mus musculus (Mouse)	403	glycine decarboxylation via glycine cleavage system [GO:0019464]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]	GO:0004047; GO:0005654; GO:0005739; GO:0008483; GO:0019464	CGI_10019480	scaffold1322	455783	455785	-100	mRNA	452220	456368
Q8CFI5	CGI_10019275	1e-125	SYPM_MOUSE	reviewed	Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)	Pars2	Mus musculus (Mouse)	475	prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	CGI_10019275	scaffold506	408656	408658	100	mRNA	406328	415042
Q8CGS4	CGI_10003741	8e-82	CHMP3_RAT	reviewed	Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24) (rVps24p)	Chmp3 Vps24	Rattus norvegicus (Rat)	223	cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; positive regulation of cytokinesis [GO:0032467]; protein transport [GO:0015031]; regulation of endosome size [GO:0051036]	cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; midbody [GO:0030496]	phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]	cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; positive regulation of cytokinesis [GO:0032467]; protein transport [GO:0015031]; regulation of endosome size [GO:0051036]	GO:0000815; GO:0005546; GO:0005769; GO:0005770; GO:0005829; GO:0007049; GO:0008333; GO:0015031; GO:0030496; GO:0031902; GO:0032467; GO:0051036; GO:0051301	CGI_10003741	scaffold1735	25054	25056	-100	mRNA	22941	26319
Q8CIV2	CGI_10015150	4e-129	MBRL_MOUSE	reviewed	Membralin (Transmembrane protein 259)	Tmem259 ORF61	Mus musculus (Mouse)	574	negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]	GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294	CGI_10015150	scaffold1671	250596	250598	100	mRNA	246040	251132
Q8IQC1	CGI_10014583	4e-51	TVP23_DROME	reviewed	Uncharacterized Golgi apparatus membrane protein-like protein CG5021	CG5021	Drosophila melanogaster (Fruit fly)	223	protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	integral component of Golgi membrane [GO:0030173]		integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	GO:0009306; GO:0016192; GO:0030173	CGI_10014583	scaffold43954	289725	289727	-100	mRNA	287551	298862
Q8IWG1	CGI_10026357	0.0	WDR63_HUMAN	reviewed	WD repeat-containing protein 63 (Testis development protein NYD-SP29)	WDR63	Homo sapiens (Human)	891	microtubule-based movement [GO:0007018]	dynein complex [GO:0030286]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]	dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule-based movement [GO:0007018]	GO:0007018; GO:0030286; GO:0045503; GO:0045504	CGI_10026357	scaffold678	422180	422182	100	mRNA	406829	423063
Q8K0U4	CGI_10004348	3e-80	HS12A_MOUSE	reviewed	Heat shock 70 kDa protein 12A	Hspa12a Kiaa0417	Mus musculus (Mouse)	675		extracellular exosome [GO:0070062]	ATP binding [GO:0005524]	extracellular exosome [GO:0070062]; ATP binding [GO:0005524]	GO:0005524; GO:0070062	CGI_10004348	scaffold1801	18657	18659	-100	mRNA	11015	28188
Q8K2Y0	CGI_10009492	1e-38	RN219_MOUSE	reviewed	RING finger protein 219	Rnf219	Mus musculus (Mouse)	722	positive regulation of mRNA splicing, via spliceosome [GO:0048026]		metal ion binding [GO:0046872]	metal ion binding [GO:0046872]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]	GO:0046872; GO:0048026	CGI_10009492	scaffold569	20108	20110	100	mRNA	180	24552
Q8K4K5	CGI_10007347	0.0	L2GL1_RAT	reviewed	Lethal(2) giant larvae protein homolog 1 (LLGL) (Rgl-1)	Llgl1 Rgl1	Rattus norvegicus (Rat)	1036	axonogenesis [GO:0007409]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]	axon [GO:0030424]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	axon [GO:0030424]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]	GO:0000137; GO:0005096; GO:0005856; GO:0005886; GO:0006887; GO:0006893; GO:0007409; GO:0017137; GO:0017157; GO:0030424; GO:0031901; GO:0032588; GO:0050708	CGI_10007347	scaffold42634	67016	67018	-100	mRNA	32186	72012
Q8N157	CGI_10027970	0.0	AHI1_HUMAN	reviewed	Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1)	AHI1	Homo sapiens (Human)	1196	cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]	identical protein binding [GO:0042802]	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]	GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097711; GO:0097730	CGI_10027970	scaffold77	181067	181069	100	mRNA	166912	189780
Q8N448	CGI_10009129	2e-106	LNX2_HUMAN	reviewed	Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1)	LNX2 PDZRN1	Homo sapiens (Human)	690	protein homooligomerization [GO:0051260]		metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]	metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein homooligomerization [GO:0051260]	GO:0030165; GO:0046872; GO:0051260	CGI_10009129	scaffold1116	120472	120474	100	mRNA	114492	125932
Q8NDA8	CGI_10011064	2e-179	MROH1_HUMAN	reviewed	Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A)	MROH1 HEATR7A KIAA1833	Homo sapiens (Human)	1641						CGI_10011064	scaffold194	184467	184469	-100	mRNA	144296	186321
Q8NFA0	CGI_10017491	0.0	UBP32_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	USP32 USP10	Homo sapiens (Human)	1604	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579	CGI_10017491	scaffold853	159874	159876	100	mRNA	141131	169627
Q8R080	CGI_10007485	1e-09	GTSE1_MOUSE	reviewed	G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99)	Gtse1 B99	Mus musculus (Mouse)	741		cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]		cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]	GO:0005881; GO:0016020	CGI_10007485	scaffold42684	152931	152933	100	mRNA	142793	153624
Q8R1S0	CGI_10021127	7e-129	COQ6_MOUSE	reviewed	Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6)	Coq6	Mus musculus (Mouse)	476	ubiquinone biosynthetic process [GO:0006744]	cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]	cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; ubiquinone biosynthetic process [GO:0006744]	GO:0005739; GO:0005743; GO:0005794; GO:0006744; GO:0016709; GO:0042995; GO:0071949	CGI_10021127	scaffold610	491044	491046	100	mRNA	486235	495587
Q8R4E0	CGI_10005133	5e-34	IRF2_SIGHI	reviewed	Interferon regulatory factor 2 (IRF-2)	IRF2	Sigmodon hispidus (Hispid cotton rat)	349	cell proliferation [GO:0008283]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	regulatory region DNA binding [GO:0000975]; transcription factor activity, sequence-specific DNA binding [GO:0003700]	nucleus [GO:0005634]; regulatory region DNA binding [GO:0000975]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; cell proliferation [GO:0008283]; transcription, DNA-templated [GO:0006351]	GO:0000975; GO:0003700; GO:0005634; GO:0006351; GO:0008283	CGI_10005133	scaffold41522	26154	26156	100	mRNA	11479	33348
Q8TCB7	CGI_10022734	1e-96	METL6_HUMAN	reviewed	Methyltransferase-like protein 6 (EC 2.1.1.-)	METTL6	Homo sapiens (Human)	284			methyltransferase activity [GO:0008168]	methyltransferase activity [GO:0008168]	GO:0008168	CGI_10022734	scaffold365	433878	433880	-100	mRNA	428149	434023
Q8TDX9	CGI_10013037	1e-96	PK1L1_HUMAN	reviewed	Polycystic kidney disease protein 1-like 1 (PC1-like 1 protein) (Polycystin-1L1)	PKD1L1 UNQ5785/PRO19563	Homo sapiens (Human)	2849	detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986]; single organismal cell-cell adhesion [GO:0016337]	calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]	calcium channel activity [GO:0005262]	calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986]; single organismal cell-cell adhesion [GO:0016337]	GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0016337; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730	CGI_10013037	scaffold1600	112304	112306	100	mRNA	112223	169446
Q8TF62	CGI_10004707	4e-131	AT8B4_HUMAN	reviewed	Probable phospholipid-transporting ATPase IM (EC 3.6.3.1) (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4)	ATP8B4 KIAA1939	Homo sapiens (Human)	1192	Golgi organization [GO:0007030]; neutrophil degranulation [GO:0043312]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phospholipid-translocating ATPase activity [GO:0004012]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phospholipid-translocating ATPase activity [GO:0004012]; Golgi organization [GO:0007030]; neutrophil degranulation [GO:0043312]	GO:0000287; GO:0004012; GO:0005524; GO:0005794; GO:0005886; GO:0007030; GO:0016021; GO:0035579; GO:0043312; GO:0070821	CGI_10004707	scaffold132	23964	23966	100	mRNA	23140	32243
Q8UUY8	CGI_10017492	9e-07	ADRB2_ONCMY	reviewed	Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)	adrb2	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	409	activation of adenylate cyclase activity [GO:0007190]; adrenergic receptor signaling pathway [GO:0071875]; negative regulation of epinephrine secretion [GO:0032811]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of lipophagy [GO:1904504]; response to peptide hormone [GO:0043434]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	beta2-adrenergic receptor activity [GO:0004941]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta2-adrenergic receptor activity [GO:0004941]; activation of adenylate cyclase activity [GO:0007190]; adrenergic receptor signaling pathway [GO:0071875]; negative regulation of epinephrine secretion [GO:0032811]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of lipophagy [GO:1904504]; response to peptide hormone [GO:0043434]	GO:0004941; GO:0005886; GO:0007190; GO:0016021; GO:0032811; GO:0043434; GO:0071875; GO:1901098; GO:1904504	CGI_10017492	scaffold853	159874	159876	100	mRNA	158430	159884
Q8UVC3	CGI_10007801	0.0	INVS_CHICK	reviewed	Inversin	INVS	Gallus gallus (Chicken)	1106	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	calmodulin binding [GO:0005516]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055	CGI_10007801	scaffold1508	64118	64120	-100	mRNA	30674	71423
Q8UVC3	CGI_10013945	6e-22	INVS_CHICK	reviewed	Inversin	INVS	Gallus gallus (Chicken)	1106	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	calmodulin binding [GO:0005516]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055	CGI_10013945	scaffold1860	157300	157302	-100	mRNA	150765	164457
Q8VHF0	CGI_10019329	0.0	MARK3_RAT	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1)	Mark3	Rattus norvegicus (Rat)	797	establishment of cell polarity [GO:0030010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; establishment of cell polarity [GO:0030010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]	GO:0000226; GO:0004674; GO:0005524; GO:0005886; GO:0030010; GO:0035331	CGI_10019329	scaffold402	456619	456621	100	mRNA	436637	465660
Q8WV92	CGI_10013614	4e-76	MITD1_HUMAN	reviewed	MIT domain-containing protein 1	MITD1	Homo sapiens (Human)	249	cell separation after cytokinesis [GO:0000920]; mitotic cytokinesis [GO:0000281]; negative regulation of protein binding [GO:0032091]; transport [GO:0006810]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]	phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cell separation after cytokinesis [GO:0000920]; mitotic cytokinesis [GO:0000281]; negative regulation of protein binding [GO:0032091]; transport [GO:0006810]	GO:0000281; GO:0000920; GO:0006810; GO:0019898; GO:0019904; GO:0030496; GO:0031902; GO:0032091; GO:0035091; GO:0042803; GO:0043231; GO:0070062	CGI_10013614	scaffold1899	231520	231522	100	mRNA	227915	236312
Q8WV93	CGI_10004178	2e-138	AFG1L_HUMAN	reviewed	AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog)	AFG1L AFG1 LACE1	Homo sapiens (Human)	481	mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]	mitochondrial membrane [GO:0031966]	ATP binding [GO:0005524]	mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]	GO:0005524; GO:0007005; GO:0031966; GO:0035694	CGI_10004178	scaffold40548	66359	66361	100	mRNA	60686	67518
Q8WXX0	CGI_10012096	0.0	DYH7_HUMAN	reviewed	Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)	DNAH7 KIAA0944	Homo sapiens (Human)	4024	cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]	GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959; GO:0060285	CGI_10012096	scaffold1195	96865	96867	100	mRNA	72745	108116
Q90Y35	CGI_10003071	9e-38	ZN622_CHICK	reviewed	Zinc finger protein 622 (Zn-finger protein C47)	ZNF622	Gallus gallus (Chicken)	405	ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; ribosomal large subunit biogenesis [GO:0042273]	GO:0003676; GO:0005634; GO:0008270; GO:0022625; GO:0030687; GO:0042273	CGI_10003071	scaffold38944	28629	28631	-100	mRNA	24963	30774
Q91048	CGI_10023907	2e-175	PTK7_CHICK	reviewed	Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7)	PTK7 KLG	Gallus gallus (Chicken)	1051	cell adhesion [GO:0007155]; convergent extension [GO:0060026]; establishment of planar polarity [GO:0001736]	integral component of plasma membrane [GO:0005887]	ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; protein tyrosine kinase activity [GO:0004713]	integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; protein tyrosine kinase activity [GO:0004713]; cell adhesion [GO:0007155]; convergent extension [GO:0060026]; establishment of planar polarity [GO:0001736]	GO:0001736; GO:0004713; GO:0005524; GO:0005887; GO:0007155; GO:0060026; GO:1904929	CGI_10023907	scaffold48	563597	563599	100	mRNA	561849	585263
Q91VA6	CGI_10020052	4e-32	PDIP2_MOUSE	reviewed	Polymerase delta-interacting protein 2	Poldip2	Mus musculus (Mouse)	368	mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	GO:0003677; GO:0005634; GO:0005739; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584	CGI_10020052	scaffold258	263612	263614	100	mRNA	253547	265969
Q91YJ2	CGI_10013637	5e-145	SNX4_MOUSE	reviewed	Sorting nexin-4	Snx4	Mus musculus (Mouse)	450	endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; vesicle organization [GO:0016050]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; SNARE complex [GO:0031201]	epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; transferrin receptor binding [GO:1990459]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; vesicle organization [GO:0016050]	GO:0005154; GO:0005158; GO:0005737; GO:0005768; GO:0005868; GO:0005886; GO:0006897; GO:0015031; GO:0016020; GO:0016050; GO:0019898; GO:0031201; GO:0031901; GO:0032456; GO:0035091; GO:0043234; GO:1903595; GO:1990459; GO:1990460	CGI_10013637	scaffold771	123347	123349	-100	mRNA	122093	127244
Q91YN5	CGI_10007751	0.0	UAP1_MOUSE	reviewed	UDP-N-acetylhexosamine pyrophosphorylase [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23)]	Uap1	Mus musculus (Mouse)	522	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0042802	CGI_10007751	scaffold483	147374	147376	100	mRNA	141773	150897
Q920N2	CGI_10012824	7e-114	BPL1_MOUSE	reviewed	Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)]	Hlcs	Mus musculus (Mouse)	722	cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]	ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin binding [GO:0009374]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]	GO:0000785; GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005652; GO:0005737; GO:0005739; GO:0005829; GO:0008283; GO:0009305; GO:0009374; GO:0016363; GO:0016570; GO:0018271; GO:0019899; GO:0042803; GO:0070781; GO:0071110	CGI_10012824	scaffold1603	184271	184273	100	mRNA	183410	203387
Q920R0	CGI_10012236	0.0	ALS2_MOUSE	reviewed	Alsin (Amyotrophic lateral sclerosis 2 protein homolog)	Als2	Mus musculus (Mouse)	1651	axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein complex [GO:0043234]; ruffle [GO:0001726]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein complex [GO:0043234]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]	GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0035023; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043087; GO:0043197; GO:0043234; GO:0043539; GO:0043547; GO:0045860; GO:0048365; GO:0048812; GO:0051036; GO:0051260	CGI_10012236	scaffold190	229430	229432	100	mRNA	218720	242617
Q922B6	CGI_10011877	2e-72	TRAF7_MOUSE	reviewed	E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)	Traf7	Mus musculus (Mouse)	594	activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein sumoylation [GO:0033235]; protein ubiquitination [GO:0016567]; regulation of protein localization [GO:0032880]; transcription, DNA-templated [GO:0006351]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein sumoylation [GO:0033235]; protein ubiquitination [GO:0016567]; regulation of protein localization [GO:0032880]; transcription, DNA-templated [GO:0006351]	GO:0000122; GO:0000151; GO:0000185; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006351; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0043231; GO:0043410; GO:0048471; GO:0071354; GO:2001235	CGI_10011877	scaffold122	225210	225212	-100	mRNA	215847	230855
Q922B6	CGI_10020331	0.0	TRAF7_MOUSE	reviewed	E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)	Traf7	Mus musculus (Mouse)	594	activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein sumoylation [GO:0033235]; protein ubiquitination [GO:0016567]; regulation of protein localization [GO:0032880]; transcription, DNA-templated [GO:0006351]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein sumoylation [GO:0033235]; protein ubiquitination [GO:0016567]; regulation of protein localization [GO:0032880]; transcription, DNA-templated [GO:0006351]	GO:0000122; GO:0000151; GO:0000185; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006351; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0043231; GO:0043410; GO:0048471; GO:0071354; GO:2001235	CGI_10020331	scaffold522	422906	422908	100	mRNA	410854	435933
Q922M3	CGI_10025652	2e-63	BACD3_MOUSE	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (mBACURD3) (BTB/POZ domain-containing protein KCTD10)	Kctd10	Mus musculus (Mouse)	315	angiogenesis [GO:0001525]; heart development [GO:0007507]; negative regulation of Notch signaling pathway [GO:0045746]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleoplasm [GO:0005654]	Notch binding [GO:0005112]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; heart development [GO:0007507]; negative regulation of Notch signaling pathway [GO:0045746]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0001525; GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0007507; GO:0016567; GO:0031463; GO:0036038; GO:0043161; GO:0045746; GO:0051260	CGI_10025652	scaffold121	463839	463841	100	mRNA	457559	465286
Q92541	CGI_10012696	1e-94	RTF1_HUMAN	reviewed	RNA polymerase-associated protein RTF1 homolog	RTF1 KIAA0252	Homo sapiens (Human)	710	blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; transcription factor activity, RNA polymerase II transcription factor binding [GO:0001076]	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; transcription factor activity, RNA polymerase II transcription factor binding [GO:0001076]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription from RNA polymerase II promoter [GO:0006366]; Wnt signaling pathway [GO:0016055]	GO:0000122; GO:0001076; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0006368; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0032968; GO:0045944; GO:0051571; GO:0080182; GO:1990269	CGI_10012696	scaffold386	309573	309575	100	mRNA	300882	313692
Q92543	CGI_10026247	3e-41	SNX19_HUMAN	reviewed	Sorting nexin-19	SNX19 KIAA0254	Homo sapiens (Human)	992	chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]	phosphatidylinositol-3-phosphate binding [GO:0032266]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; phosphatidylinositol-3-phosphate binding [GO:0032266]; chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]	GO:0002062; GO:0005737; GO:0006887; GO:0030073; GO:0030659; GO:0031901; GO:0032266; GO:1990502	CGI_10026247	scaffold867	957762	957764	100	mRNA	953403	961880
Q92604	CGI_10017167	5e-74	LGAT1_HUMAN	reviewed	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-)	LPGAT1 FAM34A KIAA0205	Homo sapiens (Human)	370	phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]	GO:0003841; GO:0005737; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0036148; GO:0045723; GO:0047144	CGI_10017167	scaffold977	186291	186293	100	mRNA	183797	188607
Q92609	CGI_10012476	3e-167	TBCD5_HUMAN	reviewed	TBC1 domain family member 5	TBC1D5 KIAA0210	Homo sapiens (Human)	795	activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; regulation of vesicle fusion [GO:0031338]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]	AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; retromer complex binding [GO:1905394]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; regulation of vesicle fusion [GO:0031338]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]	GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0010008; GO:0016236; GO:0017137; GO:0030904; GO:0031338; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0090630; GO:1905394	CGI_10012476	scaffold765	245635	245637	-100	mRNA	243118	262667
Q92621	CGI_10026576	0.0	NU205_HUMAN	reviewed	Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205)	NUP205 C7orf14 KIAA0225	Homo sapiens (Human)	2012	intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glucose transport [GO:0010827]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glucose transport [GO:0010827]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	GO:0005635; GO:0005643; GO:0006406; GO:0006409; GO:0006913; GO:0007077; GO:0010827; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0044611; GO:0051292; GO:0060964; GO:0075733; GO:1900034	CGI_10026576	scaffold145	1157968	1157970	100	mRNA	1139972	1169601
Q92628	CGI_10011359	8e-13	K0232_HUMAN	reviewed	Uncharacterized protein KIAA0232	KIAA0232	Homo sapiens (Human)	1395			ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524	CGI_10011359	scaffold1358	264637	264639	100	mRNA	261418	272401
Q93034	CGI_10001200	0.0	CUL5_HUMAN	reviewed	Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1)	CUL5 VACM1	Homo sapiens (Human)	780	cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; viral process [GO:0016032]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]	calcium channel activity [GO:0005262]; receptor activity [GO:0004872]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; calcium channel activity [GO:0005262]; receptor activity [GO:0004872]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; viral process [GO:0016032]	GO:0000082; GO:0004842; GO:0004872; GO:0005262; GO:0005829; GO:0006974; GO:0007050; GO:0008283; GO:0008285; GO:0016032; GO:0031466; GO:0031625; GO:0038128; GO:0042787; GO:0043687; GO:0080008; GO:0097193	CGI_10001200	scaffold34088	7645	7647	-100	mRNA	6736	14285
Q94BZ1	CGI_10010913	2e-20	ZIFL1_ARATH	reviewed	Protein ZINC INDUCED FACILITATOR-LIKE 1 (Protein ZIF-LIKE 1)	ZIFL1 At5g13750 MXE10.2	Arabidopsis thaliana (Mouse-ear cress)	478	basipetal auxin transport [GO:0010540]; gravitropism [GO:0009630]; regulation of stomatal closure [GO:0090333]; response to karrikin [GO:0080167]; response to water deprivation [GO:0009414]; root development [GO:0048364]	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]	potassium ion antiporter activity [GO:0022821]	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; potassium ion antiporter activity [GO:0022821]; basipetal auxin transport [GO:0010540]; gravitropism [GO:0009630]; regulation of stomatal closure [GO:0090333]; response to karrikin [GO:0080167]; response to water deprivation [GO:0009414]; root development [GO:0048364]	GO:0005886; GO:0009414; GO:0009630; GO:0009705; GO:0010540; GO:0016021; GO:0022821; GO:0048364; GO:0080167; GO:0090333	CGI_10010913	scaffold1288	66880	66882	-100	mRNA	53765	72316
Q95ZJ1	CGI_10004335	3e-138	GALT5_CAEEL	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	gly-5 Y39E4B.12	Caenorhabditis elegans	626	protein O-linked glycosylation via threonine [GO:0018243]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	GO:0000139; GO:0004653; GO:0016021; GO:0018243; GO:0030246; GO:0046872	CGI_10004335	scaffold839	53673	53675	100	mRNA	39216	58962
Q95ZJ1	CGI_10020547	1e-45	GALT5_CAEEL	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	gly-5 Y39E4B.12	Caenorhabditis elegans	626	protein O-linked glycosylation via threonine [GO:0018243]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	GO:0000139; GO:0004653; GO:0016021; GO:0018243; GO:0030246; GO:0046872	CGI_10020547	scaffold57	251019	251021	-100	mRNA	245187	251382
Q969S3	CGI_10003069	3e-56	ZN622_HUMAN	reviewed	Zinc finger protein 622 (Zinc finger-like protein 9)	ZNF622 ZPR9	Homo sapiens (Human)	477	intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]	GO:0003723; GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0008270; GO:0008631; GO:0022625; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330	CGI_10003069	scaffold38944	14013	14015	-100	mRNA	11067	20506
Q96AE7	CGI_10026556	4e-153	TTC17_HUMAN	reviewed	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	TTC17	Homo sapiens (Human)	1141	actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]		actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]	GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782	CGI_10026556	scaffold145	388000	388002	-100	mRNA	380231	413214
Q96JG6	CGI_10023639	0.0	VPS50_HUMAN	reviewed	Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)	VPS50 CCDC132 KIAA1861	Homo sapiens (Human)	964	endocytic recycling [GO:0032456]; protein transport [GO:0015031]	EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; recycling endosome [GO:0055037]	SNARE binding [GO:0000149]	EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]	GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0055037; GO:0070062; GO:1990745	CGI_10023639	scaffold583	705040	705042	100	mRNA	699513	720247
Q96JL9	CGI_10012354	5e-34	ZN333_HUMAN	reviewed	Zinc finger protein 333	ZNF333 KIAA1806	Homo sapiens (Human)	665	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872	CGI_10012354	scaffold43786	220393	220395	-100	mRNA	218616	225367
Q96KG9	CGI_10015257	0.0	SCYL1_HUMAN	reviewed	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	Homo sapiens (Human)	808	regulation of transcription, DNA-templated [GO:0006355]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; transcription, DNA-templated [GO:0006351]	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; regulation of transcription, DNA-templated [GO:0006355]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0006890; GO:0016020; GO:0030126; GO:0045296	CGI_10015257	scaffold723	114733	114735	100	mRNA	85241	116689
Q96MM6	CGI_10002794	2e-26	HS12B_HUMAN	reviewed	Heat shock 70 kDa protein 12B	HSPA12B C20orf60	Homo sapiens (Human)	686			ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524	CGI_10002794	scaffold1376	16799	16801	100	mRNA	13081	17616
Q96NN9	CGI_10006300	0.0	AIFM3_HUMAN	reviewed	Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)	AIFM3 AIFL	Homo sapiens (Human)	605	execution phase of apoptosis [GO:0097194]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]	GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194	CGI_10006300	scaffold42158	46988	46990	-100	mRNA	33625	47387
Q96RQ3	CGI_10023847	0.0	MCCA_HUMAN	reviewed	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)	MCCC1 MCCA	Homo sapiens (Human)	725	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291]	3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:0051291; GO:1905202	CGI_10023847	scaffold406	432218	432220	-100	mRNA	402781	436007
Q96RT7	CGI_10027375	1e-96	GCP6_HUMAN	reviewed	Gamma-tubulin complex component 6 (GCP-6)	TUBGCP6 GCP6 KIAA1669	Homo sapiens (Human)	1819	centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; interphase microtubule nucleation by interphase microtubule organizing center [GO:0051415]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; extracellular exosome [GO:0070062]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; extracellular exosome [GO:0070062]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; interphase microtubule nucleation by interphase microtubule organizing center [GO:0051415]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]	GO:0000922; GO:0000923; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0016020; GO:0031122; GO:0043015; GO:0051298; GO:0051321; GO:0051415; GO:0070062; GO:0090307	CGI_10027375	scaffold1179	523875	523877	100	mRNA	513646	526577
Q96SB3	CGI_10022771	7e-42	NEB2_HUMAN	reviewed	Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin)	PPP1R9B PPP1R6	Homo sapiens (Human)	815	cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to morphine [GO:0071315]; filopodium assembly [GO:0046847]; modulation of synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; nervous system development [GO:0007399]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; RNA splicing [GO:0008380]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to morphine [GO:0071315]; filopodium assembly [GO:0046847]; modulation of synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; nervous system development [GO:0007399]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; RNA splicing [GO:0008380]	GO:0000164; GO:0001560; GO:0003779; GO:0004864; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0007050; GO:0007096; GO:0007399; GO:0008157; GO:0008380; GO:0016477; GO:0030027; GO:0030154; GO:0030175; GO:0030308; GO:0032587; GO:0042127; GO:0043197; GO:0046847; GO:0050804; GO:0071315; GO:2000474	CGI_10022771	scaffold443	312701	312703	100	mRNA	301913	317743
Q99502	CGI_10019922	4e-153	EYA1_HUMAN	reviewed	Eyes absent homolog 1 (EC 3.1.3.16) (EC 3.1.3.48)	EYA1	Homo sapiens (Human)	592	anatomical structure morphogenesis [GO:0009653]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; histone dephosphorylation [GO:0016576]; lung epithelial cell differentiation [GO:0060487]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; striated muscle tissue development [GO:0014706]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein complex [GO:0043234]; protein-DNA complex [GO:0032993]	metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein complex [GO:0043234]; protein-DNA complex [GO:0032993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; histone dephosphorylation [GO:0016576]; lung epithelial cell differentiation [GO:0060487]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; striated muscle tissue development [GO:0014706]; transcription, DNA-templated [GO:0006351]	GO:0000132; GO:0001656; GO:0001658; GO:0003151; GO:0003723; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006351; GO:0007389; GO:0007501; GO:0007605; GO:0009653; GO:0010212; GO:0014706; GO:0016576; GO:0016604; GO:0016925; GO:0030154; GO:0032993; GO:0034613; GO:0035088; GO:0035909; GO:0042473; GO:0042474; GO:0043234; GO:0045664; GO:0045739; GO:0045747; GO:0045944; GO:0046872; GO:0048665; GO:0048704; GO:0048752; GO:0050679; GO:0060037; GO:0060487; GO:0071600; GO:0072513; GO:0090103; GO:2001240	CGI_10019922	scaffold1788	295445	295447	-100	mRNA	282995	305782
Q99683	CGI_10011917	0.0	M3K5_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5)	MAP3K5 ASK1 MAPKKK5 MEKK5	Homo sapiens (Human)	1374	activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein complex [GO:0043234]; protein kinase complex [GO:1902911]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein complex [GO:0043234]; protein kinase complex [GO:1902911]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]	GO:0000165; GO:0000186; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005829; GO:0006468; GO:0007254; GO:0007257; GO:0008631; GO:0009897; GO:0010666; GO:0016032; GO:0019901; GO:0019903; GO:0019904; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042803; GO:0043065; GO:0043234; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0097190; GO:0097300; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604	CGI_10011917	scaffold1874	16511	16513	100	mRNA	382	25053
Q99700	CGI_10018768	1e-48	ATX2_HUMAN	reviewed	Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein)	ATXN2 ATX2 SCA2 TNRC13	Homo sapiens (Human)	1313	cytoplasmic mRNA processing body assembly [GO:0033962]; negative regulation of receptor internalization [GO:0002091]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; Golgi apparatus [GO:0005794]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; trans-Golgi network [GO:0005802]	epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; Golgi apparatus [GO:0005794]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; negative regulation of receptor internalization [GO:0002091]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]	GO:0002091; GO:0003723; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005844; GO:0006417; GO:0008022; GO:0010494; GO:0010603; GO:0016020; GO:0016070; GO:0030529; GO:0033962; GO:0034063; GO:0048471; GO:0050658	CGI_10018768	scaffold576	266611	266613	-100	mRNA	263499	274937
Q99973	CGI_10009375	3e-31	TEP1_HUMAN	reviewed	Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)	TEP1 TLP1 TP1	Homo sapiens (Human)	2627	RNA splicing [GO:0008380]; telomere maintenance via recombination [GO:0000722]	catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear matrix [GO:0016363]; precatalytic spliceosome [GO:0071011]; telomerase holoenzyme complex [GO:0005697]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]	catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear matrix [GO:0016363]; precatalytic spliceosome [GO:0071011]; telomerase holoenzyme complex [GO:0005697]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; RNA splicing [GO:0008380]; telomere maintenance via recombination [GO:0000722]	GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005682; GO:0005697; GO:0005737; GO:0008380; GO:0016363; GO:0019899; GO:0030529; GO:0070034; GO:0071011; GO:0071013	CGI_10009375	scaffold993	145277	145279	-100	mRNA	138952	150253
Q99KW9	CGI_10008651	1e-130	TIP_MOUSE	reviewed	T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)	Itfg1 D8Wsu49e Lnkn-1 Tip	Mus musculus (Mouse)	610		extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	GO:0016021; GO:0070062	CGI_10008651	scaffold817	7467	7469	100	mRNA	6900	18319
Q9BQS8	CGI_10017792	4e-84	FYCO1_HUMAN	reviewed	FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7)	FYCO1 ZFYVE7	Homo sapiens (Human)	1478	'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098]	autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]	metal ion binding [GO:0046872]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]	autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098]	GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0006458; GO:0016020; GO:0016021; GO:0043231; GO:0044183; GO:0046872; GO:0051082; GO:0061077; GO:0072383; GO:1901098	CGI_10017792	scaffold1518	102334	102336	100	mRNA	102295	120319
Q9BUJ2	CGI_10015594	2e-147	HNRL1_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5)	HNRNPUL1 E1BAP5 HNRPUL1	Homo sapiens (Human)	856	mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription, DNA-templated [GO:0006355]; response to virus [GO:0009615]; RNA processing [GO:0006396]; transcription, DNA-templated [GO:0006351]	intracellular ribonucleoprotein complex [GO:0030529]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]	intracellular ribonucleoprotein complex [GO:0030529]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription, DNA-templated [GO:0006355]; response to virus [GO:0009615]; RNA processing [GO:0006396]; transcription, DNA-templated [GO:0006351]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006396; GO:0009615; GO:0019899; GO:0030529	CGI_10015594	scaffold1711	8682	8684	100	mRNA	1034	11661
Q9BXB4	CGI_10024079	0.0	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]	lipid binding [GO:0008289]	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	GO:0005654; GO:0005794; GO:0006869; GO:0008289; GO:0010890; GO:0031902; GO:0045444	CGI_10024079	scaffold801	227026	227028	100	mRNA	219559	232015
Q9BYN7	CGI_10019085	1e-175	ZN341_HUMAN	reviewed	Zinc finger protein 341	ZNF341	Homo sapiens (Human)	854	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0046872	CGI_10019085	scaffold507	75303	75305	100	mRNA	67789	78050
Q9BYT1	CGI_10015580	6e-121	S17A9_HUMAN	reviewed	Solute carrier family 17 member 9	SLC17A9 C20orf59	Homo sapiens (Human)	436	anion transport [GO:0006820]; exocytosis [GO:0006887]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of mitophagy [GO:1903146]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; exocytosis [GO:0006887]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of mitophagy [GO:1903146]; transmembrane transport [GO:0055085]	GO:0006820; GO:0006887; GO:0016021; GO:0022857; GO:0055085; GO:1903146; GO:1903955	CGI_10015580	scaffold44006	238821	238823	-100	mRNA	227355	240371
Q9C0G6	CGI_10020015	0.0	DYH6_HUMAN	reviewed	Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)	DNAH6 DNAHC6 DNHL1 HL2 KIAA1697	Homo sapiens (Human)	4158	cilium assembly [GO:0060271]; cilium or flagellum-dependent cell motility [GO:0001539]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium or flagellum-dependent cell motility [GO:0001539]; microtubule-based movement [GO:0007018]	GO:0001539; GO:0005524; GO:0005737; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959; GO:0060271	CGI_10020015	scaffold948	268250	268252	100	mRNA	219200	300594
Q9CQ44	CGI_10009639	1e-15	TM218_MOUSE	reviewed	Transmembrane protein 218	Tmem218	Mus musculus (Mouse)	115		cilium [GO:0005929]; integral component of membrane [GO:0016021]		cilium [GO:0005929]; integral component of membrane [GO:0016021]	GO:0005929; GO:0016021	CGI_10009639	scaffold43290	30755	30757	100	mRNA	29170	31463
Q9CQL5	CGI_10017508	8e-29	RM18_MOUSE	reviewed	39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18)	Mrpl18	Mus musculus (Mouse)	180	rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412]	extracellular space [GO:0005615]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]	extracellular space [GO:0005615]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412]	GO:0003735; GO:0005615; GO:0005739; GO:0005762; GO:0006412; GO:0008097; GO:0035928	CGI_10017508	scaffold853	366062	366064	-100	mRNA	364788	367837
Q9CSH3	CGI_10020442	0.0	RRP44_MOUSE	reviewed	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	Dis3 Kiaa1008 Rrp44	Mus musculus (Mouse)	958	CUT catabolic process [GO:0071034]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	GO:0000175; GO:0000176; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006401; GO:0016020; GO:0016075; GO:0071034	CGI_10020442	scaffold315	610944	610946	-100	mRNA	602701	614451
Q9CX99	CGI_10010584	2e-06	GRAP_MOUSE	reviewed	GRB2-related adapter protein	Grap	Mus musculus (Mouse)	217	cell differentiation [GO:0030154]; cell migration [GO:0016477]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	non-membrane spanning protein tyrosine kinase activity [GO:0004715]; receptor binding [GO:0005102]	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	GO:0004715; GO:0005102; GO:0007169; GO:0016477; GO:0030154; GO:0031234; GO:0038083; GO:0042127; GO:0045087	CGI_10010584	scaffold473	128232	128234	100	mRNA	126122	128445
Q9CXP4	CGI_10026446	1e-92	RHG08_MOUSE	reviewed	Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8)	Arhgap8	Mus musculus (Mouse)	425	regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	GTPase activator activity [GO:0005096]	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	GO:0005096; GO:0005737; GO:0007165; GO:0043087	CGI_10026446	scaffold100	645217	645219	-100	mRNA	633050	652924
Q9CYA6	CGI_10024516	3e-16	ZCHC8_MOUSE	reviewed	Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8)	Zcchc8	Mus musculus (Mouse)	709	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	GO:0003723; GO:0005654; GO:0006397; GO:0008270; GO:0008380; GO:0016604; GO:0071013	CGI_10024516	scaffold1097	273389	273391	100	mRNA	265176	274437
Q9D4W2	CGI_10001227	5e-75	CK065_MOUSE	reviewed	Uncharacterized protein C11orf65 homolog		Mus musculus (Mouse)	315						CGI_10001227	scaffold34202	5513	5515	100	mRNA	527	10844
Q9DBR7	CGI_10003201	6e-20	MYPT1_MOUSE	reviewed	Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1)	Ppp1r12a Mypt1	Mus musculus (Mouse)	1029	cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]	A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]	14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]	A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]	GO:0000278; GO:0000776; GO:0004857; GO:0005813; GO:0005829; GO:0005925; GO:0006470; GO:0007098; GO:0015629; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0035690; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071889; GO:0072357	CGI_10003201	scaffold1842	47510	47512	-100	mRNA	42810	63379
Q9EPZ8	CGI_10016416	1e-56	RN103_RAT	reviewed	E3 ubiquitin-protein ligase RNF103 (EC 2.3.2.27) (Protein ADRG34) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103) (Zfp-103)	Rnf103 Zfp103	Rattus norvegicus (Rat)	682	protein ubiquitination [GO:0016567]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]	GO:0004842; GO:0005783; GO:0005789; GO:0016021; GO:0016567; GO:0046872	CGI_10016416	scaffold1241	17048	17050	100	mRNA	15912	18704
Q9H0R3	CGI_10023286	1e-80	TM222_HUMAN	reviewed	Transmembrane protein 222	TMEM222 C1orf160	Homo sapiens (Human)	208		integral component of membrane [GO:0016021]		integral component of membrane [GO:0016021]	GO:0016021	CGI_10023286	scaffold695	432486	432488	-100	mRNA	427389	435356
Q9H3S7	CGI_10003400	1e-151	PTN23_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)	PTPN23 KIAA1471	Homo sapiens (Human)	1636	cilium assembly [GO:0060271]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0036064; GO:0043162; GO:0060271; GO:0070062; GO:1903387; GO:1903393; GO:2000643	CGI_10003400	scaffold39526	4706	4708	100	mRNA	3807	29218
Q9H8V3	CGI_10026964	0.0	ECT2_HUMAN	reviewed	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	ECT2	Homo sapiens (Human)	914	activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; cytokinesis [GO:0000910]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; cytokinesis [GO:0000910]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	GO:0000902; GO:0000910; GO:0004871; GO:0005085; GO:0005089; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0015031; GO:0017048; GO:0030496; GO:0032147; GO:0032154; GO:0032467; GO:0035023; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149	CGI_10026964	scaffold211	754715	754717	-100	mRNA	740668	755316
Q9HAU5	CGI_10020993	0.0	RENT2_HUMAN	reviewed	Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2)	UPF2 KIAA1408 RENT2	Homo sapiens (Human)	1272	animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	GO:0000184; GO:0000932; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0042162; GO:0048471	CGI_10020993	scaffold546	76513	76515	100	mRNA	71049	119321
Q9HBY0	CGI_10001451	1e-43	NOX3_HUMAN	reviewed	NADPH oxidase 3 (EC 1.6.3.-) (Mitogenic oxidase 2) (MOX-2) (gp91phox homolog 3) (GP91-3)	NOX3 MOX2	Homo sapiens (Human)	568	detection of gravity [GO:0009590]; otolith development [GO:0048840]; superoxide anion generation [GO:0042554]; temperature homeostasis [GO:0001659]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	superoxide-generating NADPH oxidase activity [GO:0016175]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; superoxide-generating NADPH oxidase activity [GO:0016175]; detection of gravity [GO:0009590]; otolith development [GO:0048840]; superoxide anion generation [GO:0042554]; temperature homeostasis [GO:0001659]	GO:0001659; GO:0005737; GO:0005886; GO:0009590; GO:0016175; GO:0042554; GO:0043020; GO:0048840; GO:0070062	CGI_10001451	scaffold35286	17331	17333	100	mRNA	5633	23296
Q9JHT5	CGI_10022980	2e-97	AMMR1_MOUSE	reviewed	AMME syndrome candidate gene 1 protein homolog	Ammecr1	Mus musculus (Mouse)	344		nucleus [GO:0005634]		nucleus [GO:0005634]	GO:0005634	CGI_10022980	scaffold348	341827	341829	100	mRNA	339377	346452
Q9M9E8	CGI_10022854	6e-16	FB92_ARATH	reviewed	F-box protein At1g78280	At1g78280 F3F9.18	Arabidopsis thaliana (Mouse-ear cress)	943		cytosol [GO:0005829]		cytosol [GO:0005829]	GO:0005829	CGI_10022854	scaffold896	491208	491210	100	mRNA	488061	495344
Q9NQV6	CGI_10009638	8e-120	PRD10_HUMAN	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10) (Tristanin)	PRDM10 KIAA1231 PFM7 TRIS	Homo sapiens (Human)	1147	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0008168; GO:0046872	CGI_10009638	scaffold43290	30755	30757	100	mRNA	17566	41943
Q9NVE4	CGI_10019244	6e-33	CCD87_HUMAN	reviewed	Coiled-coil domain-containing protein 87	CCDC87	Homo sapiens (Human)	849						CGI_10019244	scaffold980	545058	545060	100	mRNA	532284	554195
Q9NVH0	CGI_10025079	2e-108	EXD2_HUMAN	reviewed	Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (Exonuclease 3'-5' domain-like-containing protein 2)	EXD2 C14orf114 EXDL2	Homo sapiens (Human)	621	DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease I activity [GO:0008852]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease I activity [GO:0008852]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]	GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0006302; GO:0008310; GO:0008408; GO:0008852; GO:0090305	CGI_10025079	scaffold107	1009657	1009659	100	mRNA	996510	1010951
Q9NYQ6	CGI_10006474	0.0	CELR1_HUMAN	reviewed	Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)	CELSR1 CDHF9 FMI2	Homo sapiens (Human)	3014	anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G-protein coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G-protein coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]	GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004888; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005887; GO:0007156; GO:0007186; GO:0007266; GO:0007417; GO:0007626; GO:0009952; GO:0016021; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0046983; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251	CGI_10006474	scaffold42246	26199	26201	100	mRNA	5727	48525
Q9NZQ3	CGI_10018668	1e-79	SPN90_HUMAN	reviewed	NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein)	NCKIPSD AF3P21 SPIN90	Homo sapiens (Human)	722	cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]	cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165]	GO:0005634; GO:0005829; GO:0005882; GO:0006607; GO:0007010; GO:0007165; GO:0008092; GO:0010976; GO:0017124; GO:0038096	CGI_10018668	scaffold189	72397	72399	100	mRNA	68249	75941
Q9NZW4	CGI_10005214	2e-06	DSPP_HUMAN	reviewed	Dentin sialophosphoprotein [Cleaved into: Dentin phosphoprotein (Dentin phosphophoryn) (DPP); Dentin sialoprotein (DSP)]	DSPP	Homo sapiens (Human)	1301	biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; skeletal system development [GO:0001501]	GO:0001501; GO:0001503; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005578; GO:0005737; GO:0007275; GO:0030198; GO:0031214	CGI_10005214	scaffold1191	103584	103586	-100	mRNA	103097	120475
Q9P2D0	CGI_10015408	3e-85	IBTK_HUMAN	reviewed	Inhibitor of Bruton tyrosine kinase (IBtk)	IBTK BTKI KIAA1417	Homo sapiens (Human)	1353	negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209	CGI_10015408	scaffold616	418343	418345	100	mRNA	405918	425935
Q9QXG4	CGI_10021968	0.0	ACSA_MOUSE	reviewed	Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme)	Acss2 Acas2 Acecs1	Mus musculus (Mouse)	701	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006085; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231	CGI_10021968	scaffold1108	243090	243092	100	mRNA	231754	246089
Q9QYE0	CGI_10024836	2e-67	PLAG1_MOUSE	reviewed	Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein)	Plag1	Mus musculus (Mouse)	499	apoptotic process [GO:0006915]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; prostate gland growth [GO:0060736]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; apoptotic process [GO:0006915]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; prostate gland growth [GO:0060736]	GO:0000978; GO:0000981; GO:0001077; GO:0005634; GO:0006915; GO:0010628; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0035265; GO:0045944; GO:0046872; GO:0060252; GO:0060736	CGI_10024836	scaffold492	443584	443586	-100	mRNA	440262	450143
Q9R0D8	CGI_10014377	1e-76	WDR54_MOUSE	reviewed	WD repeat-containing protein 54	Wdr54 D3Mm3e	Mus musculus (Mouse)	334						CGI_10014377	scaffold1462	240563	240565	-100	mRNA	239144	245171
Q9R1P4	CGI_10008810	8e-128	PSA1_MOUSE	reviewed	Proteasome subunit alpha type-1 (EC 3.4.25.1) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	Psma1	Mus musculus (Mouse)	263	immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]	lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0004298; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0006511; GO:0019773; GO:0070062	CGI_10008810	scaffold43116	81040	81042	-100	mRNA	77947	82972
Q9R1R2	CGI_10001358	3e-13	TRIM3_MOUSE	reviewed	Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1)	Trim3 Hac1 Rnf22	Mus musculus (Mouse)	744	protein transport [GO:0015031]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]	GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0061630	CGI_10001358	scaffold34756	3725	3727	-100	mRNA	21	10691
Q9U1M8	CGI_10002584	2e-159	MYOI_DICDI	reviewed	Myosin-I heavy chain (Class VII unconventional myosin) (DdMVII) (DdM7)	myoI DDB_G0274455	Dictyostelium discoideum (Slime mold)	2357	actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847]	GO:0000902; GO:0001891; GO:0003774; GO:0003779; GO:0005524; GO:0005829; GO:0006909; GO:0008017; GO:0009847; GO:0016020; GO:0016459; GO:0030048; GO:0030175; GO:0030898; GO:0031252; GO:0031589; GO:0043621; GO:0046847; GO:0051015	CGI_10002584	scaffold884	36972	36974	-100	mRNA	1610	37089
Q9UBB5	CGI_10011651	4e-77	MBD2_HUMAN	reviewed	Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2)	MBD2	Homo sapiens (Human)	411	aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein complex assembly [GO:0043623]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; transcription, DNA-templated [GO:0006351]	cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein complex [GO:0043234]	C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]	cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein complex [GO:0043234]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein complex assembly [GO:0043623]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; transcription, DNA-templated [GO:0006351]	GO:0000118; GO:0000122; GO:0000183; GO:0000790; GO:0000792; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006346; GO:0006351; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0043044; GO:0043234; GO:0043623; GO:0044030; GO:0045892; GO:0048568; GO:0070742; GO:0071407	CGI_10011651	scaffold787	267430	267432	-100	mRNA	251947	273262
Q9UHB9	CGI_10020564	2e-169	SRP68_HUMAN	reviewed	Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)	SRP68	Homo sapiens (Human)	627	protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	GO:0003723; GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0005840; GO:0005925; GO:0006614; GO:0008312; GO:0019904; GO:0030942; GO:0042493; GO:0045047; GO:0048500	CGI_10020564	scaffold57	511346	511348	100	mRNA	506826	512408
Q9UHJ3	CGI_10006381	0.0	SMBT1_HUMAN	reviewed	Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1)	SFMBT1 RU1	Homo sapiens (Human)	866	cell differentiation [GO:0030154]; covalent chromatin modification [GO:0016569]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; covalent chromatin modification [GO:0016569]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]	GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0007283; GO:0016569; GO:0030154; GO:0042393; GO:0045892; GO:0048635	CGI_10006381	scaffold1774	66117	66119	100	mRNA	62955	76692
Q9UII5	CGI_10011721	3e-51	ZN107_HUMAN	reviewed	Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25)	ZNF107 ZFD25 ZNF588	Homo sapiens (Human)	783	regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872	CGI_10011721	scaffold43664	258686	258688	100	mRNA	252147	258856
Q9UJX5	CGI_10027235	1e-112	APC4_HUMAN	reviewed	Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)	ANAPC4 APC4	Homo sapiens (Human)	808	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051439]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051439]	GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0019903; GO:0030071; GO:0031145; GO:0042787; GO:0043161; GO:0051301; GO:0051436; GO:0051437; GO:0051439; GO:0070979	CGI_10027235	scaffold481	722098	722100	100	mRNA	717173	750597
Q9UKD2	CGI_10014965	2e-94	MRT4_HUMAN	reviewed	mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4)	MRTO4 C1orf33 MRT4	Homo sapiens (Human)	239	nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364	CGI_10014965	scaffold43988	59236	59238	100	mRNA	49566	61691
Q9UKU7	CGI_10023025	0.0	ACAD8_HUMAN	reviewed	Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.99.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; valine catabolic process [GO:0006574]	GO:0003995; GO:0005759; GO:0006351; GO:0006355; GO:0006574; GO:0006629; GO:0009083; GO:0050660	CGI_10023025	scaffold1101	429441	429443	100	mRNA	427519	433029
Q9ULV0	CGI_10005126	0.0	MYO5B_HUMAN	reviewed	Unconventional myosin-Vb	MYO5B KIAA1119	Homo sapiens (Human)	1848	endosome localization [GO:0032439]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]	apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein complex [GO:0043234]	actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein complex [GO:0043234]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; endosome localization [GO:0032439]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]	GO:0000146; GO:0003091; GO:0003779; GO:0005516; GO:0005524; GO:0015031; GO:0016192; GO:0016459; GO:0017137; GO:0030659; GO:0032439; GO:0043234; GO:0045179; GO:0070062	CGI_10005126	scaffold41480	51476	51478	-100	mRNA	9841	73363
Q9UP83	CGI_10012067	0.0	COG5_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1)	COG5 GOLTC1 GTC90	Homo sapiens (Human)	839	ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]		cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588	CGI_10012067	scaffold1492	5116	5118	-100	mRNA	1897	16561
Q9VX32	CGI_10028030	7e-163	RG190_DROME	reviewed	Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)	RhoGAPp190 CG32555	Drosophila melanogaster (Fruit fly)	1561	defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]	intracellular [GO:0005622]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]	intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]	GO:0003924; GO:0005096; GO:0005525; GO:0005622; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770	CGI_10028030	scaffold77	1269384	1269386	100	mRNA	1265470	1292938
Q9W1W9	CGI_10025081	1e-42	PADC1_DROME	reviewed	PRADC1-like protein (PAP21-like protein)	CG9849	Drosophila melanogaster (Fruit fly)	196	muscle cell fate determination [GO:0007521]	extracellular region [GO:0005576]		extracellular region [GO:0005576]; muscle cell fate determination [GO:0007521]	GO:0005576; GO:0007521	CGI_10025081	scaffold107	1026788	1026790	-100	mRNA	1026222	1027896
Q9WU70	CGI_10019031	0.0	STXB5_RAT	reviewed	Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)	Stxbp5 Llgl3	Rattus norvegicus (Rat)	1152	exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of blood coagulation [GO:0030193]; regulation of gene expression [GO:0010468]; regulation of protein secretion [GO:0050708]	cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; syntaxin-1 binding [GO:0017075]	cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of blood coagulation [GO:0030193]; regulation of gene expression [GO:0010468]; regulation of protein secretion [GO:0050708]	GO:0005096; GO:0005829; GO:0005886; GO:0006887; GO:0008021; GO:0010468; GO:0015031; GO:0016021; GO:0017075; GO:0017137; GO:0030054; GO:0030141; GO:0030193; GO:0030659; GO:0045921; GO:0050708	CGI_10019031	scaffold808	421426	421428	100	mRNA	381951	433040
Q9Y2G3	CGI_10003316	0.0	AT11B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IF (EC 3.6.3.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)	ATP11B ATPIF ATPIR KIAA0956	Homo sapiens (Human)	1177	aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phospholipid-translocating ATPase activity [GO:0004012]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phospholipid-translocating ATPase activity [GO:0004012]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	GO:0000287; GO:0004012; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038	CGI_10003316	scaffold1690	29959	29961	-100	mRNA	9012	64265
Q9Y4A5	CGI_10005249	0.0	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	kinase activity [GO:0016301]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription cofactor activity [GO:0003712]	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; kinase activity [GO:0016301]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription cofactor activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006351; GO:0006355; GO:0016301; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0036459; GO:0043967; GO:0043968; GO:1904837	CGI_10005249	scaffold41534	39494	39496	100	mRNA	459	65052
Q9YHZ6	CGI_10023236	0.0	CDC45_XENLA	reviewed	Cell division control protein 45 homolog	cdc45 cdc45l	Xenopus laevis (African clawed frog)	567	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	GO:0003682; GO:0005654; GO:0006270; GO:0007049	CGI_10023236	scaffold408	405119	405121	-100	mRNA	398041	414352
Q9Z1J2	CGI_10010191	3e-53	NEK4_MOUSE	reviewed	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2)	Nek4 Stk2	Mus musculus (Mouse)	792	activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of mitotic cell cycle [GO:0007346]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cilium [GO:0005929]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]	cilium [GO:0005929]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of mitotic cell cycle [GO:0007346]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005929; GO:0006468; GO:0006974; GO:0007346; GO:0023014; GO:0030145; GO:0031098; GO:0032147; GO:0042981; GO:0045893; GO:0051301; GO:1900062; GO:2000772; GO:2001020	CGI_10010191	scaffold930	136454	136456	-100	mRNA	116124	137897
